Louisiana State University

LSU Digital Commons
LSU Doctoral Dissertations

Graduate School

2015

The Effects of Post-Exercise Consumption of a Kefir Beverage on
Performance and Recovery During Intensive Endurance Training
Keely Virginia O'Brien
Louisiana State University and Agricultural and Mechanical College

Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_dissertations
Part of the Animal Sciences Commons

Recommended Citation
O'Brien, Keely Virginia, "The Effects of Post-Exercise Consumption of a Kefir Beverage on Performance
and Recovery During Intensive Endurance Training" (2015). LSU Doctoral Dissertations. 3594.
https://digitalcommons.lsu.edu/gradschool_dissertations/3594

This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It
has been accepted for inclusion in LSU Doctoral Dissertations by an authorized graduate school editor of LSU
Digital Commons. For more information, please contactgradetd@lsu.edu.

THE EFFECTS OF POST-EXERCISE CONSUMPTION OF A KEFIR BEVERAGE
ON PERFORMANCE AND RECOVERY DURING INTENSIVE ENDURANCE
TRAINING

A Dissertation
Submitted to the Graduate Faculty of the
Louisiana State University and
Agricultural and Mechanical College
in partial fulfillment of the
requirements for the degree of
Doctor of Philosophy
in
The Interdepartmental Program in
The School of Animal Sciences

by
Keely Virginia O’Brien
B.S., University of Tennessee, 2007
M.S., Louisiana State University, 2012
May 2015

ACKNOWLEDGEMENTS
Thanks are owed to Dr. Charles Boeneke and Dr. Laura Stewart for making this project
possible, and to Dr. Kayanush Aryana, Dr. Witoon Prinyawiwatkul and Dr. Carol O’Neil,
my doctoral committee members. I would like to acknowledge Laura Bobart and all of
the time (and patience) she spent helping me in the lab. Thanks to all my professors and
friends who made this an exciting and challenging experience. Finally, I would like to
thank my family for their unwavering love and support.

ii

TABLE OF CONTENTS
ACKNOWLEDGEMENTS…………….............................................................................ii
LIST OF TABLES………………………………………………………………………..vi
LIST OF FIGURES………………………………………………………………......…viii
ABSTRACT………………………………………………………………………..….....ix
CHAPTER 1. INTRODUCTION
1.1 Fermented Milk: History and Principles……………………………………………....1
1.2 Kefir Definition and Origins…………………………………………………………..3
1.3 Kefir Starter Culture…………………………………………………………………..4
1.3.1 Microflora……………………………..………………………...………………...8
1.3.1.1 Lactobacilli……………………………………………………………………...9
1.3.1.2 Lactococci……………………………………………………………………...10
1.3.1.3 Yeasts…………………………………………………………………………..10
1.3.2 Kefiran………………………………………………………………………...…12
1.4 Physiochemical and Sensory Characteristics of Kefir……………………………….15
1.5 Kefir Production Methods and Consumer Preferences……………………………....17
1.6 Health Benefits of Probiotics and Kefir……………………………………………...18
1.7 Physiological Effects of Endurance Exercise…………………………..……………22
1.7.1 Metabolic Effects………………………………………………………………...22
1.7.2 Immune Function.………………………………………………………………..23
1.7.3 Inflammation.………..………………………………………….………………..25
1.8 Biological Measures of Inflammation and Immune Functioning…………….……...26
1.9 Sport Nutrition……………………………………………………………..………...28
1.10 Probiotics and Exercise……………………………………………………………..30
1.11 The Role of Dairy Foods in Sport Nutrition………………………….…………….31
1.12 Objectives…………………………………………………………………………..34
CHAPTER 2. MATERIALS AND METHODS………………………………………..35
2.1 Experimental Design………………………………………………………………...35
2.2 Product Development………………………………………………………………..36
2.2.1 Fermented Milk Beverage……………………………………………………….36
2.2.2 Control Beverage………………………………………………………………...37
2.2.3 Quality Control Testing..................……………………………………………...38
2.2.4 Nutritional Analysis.…………………………....………………………………..38
2.3 Subject Recruitment………………………………………………………………….39
2.4 Medical and Health History Screening.......................……………………………….40
2.5 Pre-Intervention Data Collection: Baseline Resting Measurements.…..............….....41
2.5.1 Body Circumference/Body Composition………………………………………...41
2.5.2 Saliva Collection…………………………………………………………………42
2.5.3 Blood Collection………………………………………………………………....42
2.5.4 Timed 1.5 Mile Run/Walk……………………………………………………….43

iii

2.6 Exercise Training…………………………………………………………………….43
2.7 Kefir Supplementation……………………………………………………………….44
2.8 Sickness and Injury Questionnaires………………………………………………….44
2.9 Athlete Burnout Questionnaire………………………………………………………44
2.10 Sensory Surveys…………………………………………………………………….45
2.11 Post-Intervention Data Collection…………………………………………………..46
2.12 Sample Analysis: Enzyme-Linked Immuno-Sorbent Assay (ELISA) …………......46
2.12.1 CRP ELISA…………………………………………………………..…………47
2.12.2 TNF-α ELISA………..……………………………………………………...….48
2.12.3 SIgA ELISA................………………………………………………….………50
2.13 Statistical Analysis………………………………………………………………….53
CHAPTER 3. RESULTS AND DISCUSSION…………………………………………54
3.1 Endurance Training…………………………………………………………………..54
3.2 Body Density and Percent Body Fat.………………………………………………...56
3.3 C-Reactive Protein…………………………………………………………………...59
3.4 Tumor Necrosis Factor-α…...……………………………………………………......61
3.5 Frequency of Sickness and Injury…………..………………………………………..63
3.6 Athlete Burnout……...…………………………………………………………….....66
3.7 Consumer Survey and Sensory Analysis...…………………………………………..68
3.8 Limitations…………………………………........…………………………………...71
CHAPTER 4. CONCLUSIONS AND FUTURE WORK………………………………74
REFERENCES…………………………………………………………………………..76
A IRB APPROVAL FORM…………………………………………………….……….92
B TRAINING DOCUMENTS....………………………………………………………..93
1.1 The Physiology of Endurance Training: Course Flyer...….…….…………………93
1.2 Marathon Training Schedule………………………….....………………………...94
C CONSENT FORMS……………………………………………………………….….95
2.1 Research Consent Form – Product Information…………………………………...95
2.2 Participant Consent Form – Explanation of Research Protocols……………….…96
2.3 Physician Approval Form for Participation in Marathon Training…………...…...99
D PHYSICAL ACTIVITY ASSESSMENT FORMS…………………………………100
3.1 Physical Activity Readiness Questionnaire (PAR-Q)…………………………....100
3.2 International Physical Activity Questionnaire (IPAQ)…………………………..101
E RECURRING SURVEYS…………………………………………………………...103
4.1 Baseline Measurement Worksheet…………………………………………….…103
4.3 Weekly Self-Report Injury Questionnaire…………………………………….....104
4.4 Weekly Sickness Self-Assesment Questionnaire………………………………...105
4.5 Athlete Burnout Questionnaire (ABQ)……………………………………..........106

iv

F SENSORY EVALUATION FORMS…………………………………………….....107
5.1 Preliminary Sport Nutrition Survey……………………………………………...107
5.2 Product Evaluation Survey……………………………………………………....108
5.3 Exit Survey…………………………………………………………………….....109
G RAW DATA………………………………………………………………………..110
VITA…………………………………………………………………………………....116

v

LIST OF TABLES
Table 1. Average number of colony-forming units (CFUs) of probiotic microorganisms
found in 1 gram (g) of traditionally produced kefir...........................................................8
Table 2. Bacterial species commonly found in kefir and kefir grains………….….…….9
Table 3. Species of yeasts reported in kefir grains of various origins…………………..11
Table 4. CRP concentration in plasma and correlated risk of coronary heart disease…..28
Table 5. Macronutrient recommendations for athletes following exercise……………...28
Table 6. Treatment group and sample size for subjects participating in a 15-week
marathon training program and receiving a supplemental recovery beverage............…..35
Table 7. Nutrient profile of recovery beverage given to endurance athletes participating
in a 15-week marathon training program and an active control........................................38
Table 8. Composition of a kefir beverage given to endurance athletes and an active
control during a 15-week marathon training program......................................................39
Table 9. Composition of a dairy-based control beverage given to endurance athletes and
an active control during a 15-week marathon training program........................................39
Table 10. Average percent change in 1.5-mile walk/run times for endurance training
athletes and an active control consuming a kefir recovery beverage and a control
beverage. ……………………………………………………...........................................55
Table 11. Equations used for the calculation of body density and percent body fat based
on skinfold data collected during resting baseline measurements……………………….56
Table 12. Descriptive categories for ranges of body fat percentage ranges in women and
men issued by The American Council of Exercise............................................................59
Table 13. Average reported sickness for endurance training athletes and an active control
consuming a kefir recovery beverage and a control beverage during a 15-week marathon
training program.................................................................................................................64
Table 14. Average number of injuries for endurance training athletes and an active
control consuming a kefir recovery beverage and a control beverage during a 15-week
marathon training program................................................................................................66
Table 15. Three measures of athlete burnout in athletes and an active control consuming
a kefir recovery beverage and a control beverage during a 15-week endurance training
program.……………………………………………………………….............................67

vi

Table 16. Reported consumption of yogurt and other fermented dairy products by college
students (age 18-30 yrs) participating in a marathon-training program and an active
control……………………………………………………………………………………69
Table 17. Product acceptability and consumer intent of purchase for a kefir based postexercise recovery beverage and a control beverage by athletes participating in a 15-week
marathon training program and an active control ………………...……......................…71

vii

LIST OF FIGURES
Figure 1. Lactic acid fermentation and alcoholic fermentation…………………………..3
Figure 2. Macroscopic structure of kefir grains ………………………………………….5
Figure 3. Scanning electron microscopy of Brazilian kefir grain microbiota…………...13
Figure 4. Proposed health benefits associated with the consumption of probiotics…….19
Figure 5. Probiotics modulate immune function in the mucosa through interaction with
M-cells in the Peyer’s Patch, intestinal epithelial cells and dendritic cells……………...20
Figure 6. Rates of appearance of circulating glucose and free fatty acids during exercise
at graded intensities in humans…………………………………………………………..22
Figure 7. Model of the proposed neuroendocrinological mechanisms underlying the
exercise induced “open window” in the immune system………………………………..24
Figure 8. Experimental design…………………………………………………………..36
Figure 9. Mean 1.5 mile time for subject groups before and after the 15-week
intervention………………………………………………………………………………54
Figure 10. Body density of study participants before and after the 15-week
intervention……………………………………………………………………………....57
Figure 11. Percent body fat of study participants before and after the 15-week
intervention………………………………………………………………………………58
Figure 12. Effect of endurance training and kefir supplementation on serum C-reactive
protein (mg/L)……………………………………………………………………………60
Figure 13. Effect of endurance training and kefir supplementation on TNF-α (pg/ml)...62
Figure 14. Total reported sickness during the 15-week intervention period…………....64
Figure 15. Total reported injury during the 15-week intervention period………………65
Figure 16. Sensory analysis of kefir recovery beverage and control…………………....70

viii

ABSTRACT
This study was designed to determine whether kefir accentuates the positive health
benefits assessed by measures in fitness and/or body composition, as a measure of
cardiovascular disease risk as well as the biomarker c-reactive protein. Sixty-seven adult
males and females aged 18-35 years were assigned to one of four groups: 1) endurance
training + control beverage, 2) endurance training + kefir beverage, 3) active control +
control beverage or 4) active control + kefir beverage. The exercise groups completed
15 weeks of structured endurance training while the active control groups maintained
their usual exercise routine. Baseline physiological and exercise measurements were
collected pre-intervention and post-intervention. Blood and saliva samples were analyzed
for C-reactive protein, tumor necrosis factor-alpha and secretory immunoglobulin A.
Instances of sickness and illness throughout the intervention were also examined.
Additionally, each group was assigned to either a kefir or a calorie/macronutrient
matched placebo beverage that was consumed twice per week. The endurance training
protocol was effective as demonstrated by a significant improvement (p<0.05) in the 1.5mile times of the endurance training groups.

The endurance training groups also

experienced a significantly higher (p<0.05) number of sicknesses than the active control
groups. There were no significant interactions among groups with respect to
physiological outcome variables with the exception of serum C-reactive protein. The
endurance training group receiving a control beverage demonstrated a significant increase
(p<0.05) in C-reactive protein following the 15 week training program while the
endurance training group receiving a kefir beverage had no significant change in Creactive protein. Although the reported sickness was not significantly different between
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the endurance training group + kefir beverage and the endurance training group + control
beverage, kefir supplementation may have been a factor in attenuating the increase in Creactive protein that was observed over the course of the intervention period. This
preliminary study suggests that kefir may be involved in improving the risk profile for
cardiovascular disease as defined by C-reactive protein.
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CHAPTER 1. INTRODUCTION
1.1 Fermented Milk: History and Principles
Evidence of fermented milk production dates back to 7000 BCE with origins in
the middle and far-east of Asia, making it one of the oldest methods of both temporary
and long term food preservation. A further spreading east of these traditions, by way of
Russia and Eastern Europe, by the Tartars, Mongols and Huns occurred during the
expansion and conquests by these empires (Vasiljevic, et. al., 2008). The expansion of
cultures that maintained livestock as a source of meat and dairy foods by the introduction
of herds and traditional production methods, and subsequent industrialization of dairy
food production, has led to a total worldwide domestic ruminant population of nearly
three billion at the beginning of the twenty-first century (Weimer, 2001).
Cultures that were traditionally associated with herding or keeping livestock,
including cattle, sheep, goats, mares or water buffalo, discovered and, over the course of
many generations, refined the process of milk preservation. This ultimately led to the
wide the range of fermented milks produced today, which are as diverse as the cultures
that produce them. From the traditional sour milks of Eastern Europe to the hard salty
cheeses first developed throughout the Mediterranean region, cultured dairy products
have been a dietary staple for humans throughout recorded history, and although unaware
of the microbiological processes involved, traditions and protocols were established
within herding communities that ensured the methodologies and knowledge required to
produce the flavors and textures associated with specific fermented dairy products were
kept intact. Often, these practices were passed down from generation to generation
within local communities, feudal states and monasteries (Caplice, et. al., 1999). Over
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time, the tastes associated with fermented milks, such as the characteristic acidic flavor,
may have also become associated with increased health and longevity, thus furthering its
spread and increasing manufacture throughout and within ancient populations.
It was not until the late nineteenth century that scientists first began to take note
that there were factors present in fermented milks that may be providing health benefits
to the consumer that were beyond the scope of non-fermented milk. This realization
sparked early microbiological work involving milk and fermented food products by
numerous scientists, including Nobel Laureate Elie Metchnikoff, who correlated a large
consumption of fermented milk to an above average life span.

In populations of

Bulgarian peasants consuming ‘sour milk’, he noticed that the average life span was
eighty-seven years old, with one out of four living past one hundred years of age
(Vasiljevic, 2008). Following suit, scientists such as Grigoroff (1905) and Rettger, et. al.
(1914), as well as Metchnikoff himself (1905) were isolating bacteria from fermented
milks and demonstrating that certain strains could survive and colonize the intestinal tract
Fermentation is defined as the conversion of carbohydrates to organic acids or
alcohol and carbon dioxide, using bacteria and yeasts, or a combination thereof, under
anaerobic conditions (Kosikowski, et. al., 1999). In milk, these fermentations most often
occur as a result of the hydrolysis of lactose by lactic acid bacteria containing the enzyme
β-galactosidase. Lactic acid bacteria prefer lactose as their source of carbon, and the end
products can be exclusively lactic acid or a combination of lactic acid and other
metabolic end products, such as acetic acid, carbon dioxide and hydrogen (Alfa-Laval,
1987). Yeasts, such as Saccharomyces cerevisiae, are also capable of fermenting lactose
and other sugars and can be found in some fermented milks (Kwak, et. al., 1996). The
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steps involved in the fermentation of glucose by lactic acid bacteria and yeasts are
outlined in Figure 1.
Glucose
Glycolysis
2 pyruvic acids
Lactic acid fermentation

Alcoholic fermentation
2 acetalaldehydes

2 lactic acids

2 ethanols

Figure 1. Lactic acid fermentation and alcoholic fermentation.
It also important to note that while the production of lactic acid from the
fermentation of lactose contributes to the characteristic acidity associated with fermented
milks, many interesting parallel post fermentation reactions often occur with other
substrates, such as peptones, peptides and fatty acids to produce some of the distinctive
flavors associated with cultured products.
1.2 Kefir Definition and Origin
Due to a growing consumer awareness and demand for foods with added or
naturally occurring probiotics, a fermented milk called “kefir” is gaining in popularity
and commercial production of kefir-like products has greatly increased over the past
several years. Kefir is a naturally fermented milk beverage with a smooth and creamy
texture and has an acidic and slightly alcoholic and yeasty taste; the presence of carbon
dioxide gives a varying degree of effervescence (Farnsworth, 1999). In fact, the word
kefir is derived from the Turkish word ‘kef’, which means pleasant taste (Kurmann, et.
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al., 1992).

Kefir originated in the Caucasus Mountains several centuries ago and was

traditionally produced with caprine milk by inhabitants closely associated with the
herding of goats and sheep.
Kefir has a rich history as it pertains to its genesis and spread throughout the
regions of the Balkan and Caucasus regions of Eastern Europe; in fact, the origins of kefir
predate written records (Rosell, 1932). Because of its ancient and apparently mysterious
origin, kefir was known in antiquity as the ‘Drink of the Prophet [Mohammad]’ and the
culture used to prepare it as the ‘Grains of the Prophet Mohammad’. It was believed that
the Prophet of Islam, Mohammad, was given the original kefir grains by the Angel
Gabriel to be given to his followers, thus introducing kefir to the Orthodox Christians
living in the mountainous regions of modern day Georgia (Margulis, 1996). A recent
study by Yang, et. al. (2015) presented direct proteomic evidence for production of kefir
that was found as an organic mass associated with the mummies of an Early Bronze Age
(1980–1450 BCE) cemetery in Xinjiang, China.
1.3 Kefir Starter Culture
Kefir differs from other fermented milk products in its unique starter culture, which
is an aggregation of many different bacteria and yeast species bound together in an
exopolysaccharide (EPS) matrix produced by certain lactic acid bacteria in the presence of
yeast (Figure 2). Farnsworth (1999) describes kefir grains as a mass of bacteria, yeasts,
polysaccharides, and other products of bacterial metabolism, together with curds of milk
proteins. The starter cultures, termed “grains”, grow, propagate and pass their properties
along to the following generations of grains (Simova, et. al., 2002).
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Figure 2. Macroscopic structure of kefir grains. (source: De Oliveira Leite, et. al., 2013:
Creative Commons License CC BY-NC)
When describing the perpetuation of kefir grains by certain groups throughout
history Rosell (1932) said, “One of the things that puzzle investigators in regard to the
preparation of these milks [kefir] is that most of the races named are those who have kept
kefir in its pure form. The method of their preparation was handed down as a precious
inheritance from father to son in the families who concerned themselves with these
products of ancient lineage, which, in a certain sense, may be said to constitute the ‘secret
medicine’ of many countries.” It is the production of kefir and the propagation of the
starter culture, using the traditional methods that preserve its defining characteristics, which
have remained intact due to the preservation of the complex diversity and delicate balance
of the microbial communities of the grains.
The fermentation of fresh milk is accomplished by the addition of the kefir grains,
which may contain up to 50 bacterial species from genera including lactobacilli, lactococci,
leuconostocs, acetobacter, enterococci and micrococci and up to 30 different yeast species
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from genera such as kluvermyces and sacromyces; the strains are bound together by the
exopolysaccharide kefiran, which is produced by the bacterial species Lactobacillus
kefiranofaciens (Kwak, et. al., 1996; Diosma, et. al., 2014; Garofalo, et. al., 2015). The
yellowish, white structures resemble small cauliflower florets and have a firm gel texture;
the average kefir grain is approximately the size of a small marble with a weight of 0.5-1.5
grams (g), although individual grains can vary greatly in size and shape. The grains
typically range in size from 0.3 to 3.5 centimeters (cm) in diameter; however some grains
have been reported to grow much larger (Garrote, et. al., 1997). They are insoluble in
water and ordinary solvents, and when immersed in milk the grains initiate the dual lactic
acid and alcohol fermentations (Kosikowski, et. al., 1999). Zourari, et. al. (1988) reports
the chemical composition of kefir grains as 890-900 grams/kilogram (g/kg) water, 2 g/kg
lipid, 30 g/kg protein, 60 g/kg sugars and 7 g/kg ash.
Fermentation of milk with the kefir grains proceeds for approximately 24 hours.
An initial drop in the pH is caused by the rapid growth of heterofermentative streptococci
bacteria; the lowered pH favors the growth of lactobacilli, but causes the streptococci
numbers to decline. The presence of yeasts in the kefir grains, along with the
fermentation temperature (approximately 25°C) encourages the growth of aromaproducing heterofermentative streptococci. During the final stages of the initial
incubation and during subsequent storage, growth of lactic acid bacteria is favored over
growth of yeasts and acetic acid bacteria (Farnsworth, 2003 and Koroleva, 1988).
The microflora of kefir grains is remarkably stable, retaining its activity for years
if preserved and incubated under the necessary physiological conditions required for the
continued propagation the probiotic species (Simova, et. al., 2002).
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According to

Garrote, et. al. (1997), wet kefir grains will only retain activity for only 8-10 days if not
inoculated into fresh milk, while dried grains retain activity for 12-18 months.
Studies have shown that grains from different geographic regions vary widely in
composition, which can result in large variance in the finished kefir products (Marshall, et.
al., 1984; Pintado, et. al., 1996; Simova, et. al., 2002; Wang, et. al., 2008). In addition, the
microbiologic study of kefir is complicated by the constant evolution of identification and
the related nomenclature of bacteria, often causing difficulties when comparing data
between labs or with previous reports (Farnsworth, 1999).
In studies using electron microscopy to examine the structure and composition of
kefir grains, Bottazzi, et. al. (1980) suggested that the yeasts and lactobacilli are not
randomly distributed in the grain; the lactobacilli were associated with the periphery of the
grain and the majority of yeasts located inside the grain. The source of the kefir grains for
this study were only identified as “obtained from a commercial source”, which may pose
problems as grains from various regions may vary structurally in terms of distribution of
the microflora as the species present varies between grains sourced from different
sources/regions. In a 2005 study examining the microflora of Turkish kefir grains, GuzelSeydem, et.al. found a ratio of 109:106 of lactic acid bacteria and yeasts, with lactobacilli
species predominating, and no significant fluctuation during storage. However, previous
studies on Irish kefir grains, performed by Rea, et. al. (1996) showed the contents of grains,
reported in colony forming units per milliliter (cfu/ml) of lyophilized sample, to be 109
lactococci, 108 leuconostocs, 106 lactobacilli, 105 acetic acid bacteria and 106 yeasts (see
Table 1).
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Table 1. Average number of colony-forming units (CFUs) of probiotic microorganisms
found in 1 gram (g) of traditionally produced kefir.
Genus
Lactococcus
Leuconostocs
Lactobacillus
Yeasts
Acetobacter

CFU per gram
1,000,000,000
100,000,000
5,000,000
1,000,000
100,000

(adapted from: Guzel-Seydem, et.al., 2005)
The weight percentage of kefir grains used to inoculate the milk has been shown
to have a significant effect on the numbers of different microorganisms found in the
finished product. When using a 1% by milk weight ratio of grains, lactobacilli and
lactococci levels were found at the highest levels at the end of a 30 day storage period;
when a 5% inoculate was used yeasts and acetic acid counts were highest after 72 hours
(Irigoyen, et. al., 2005). Similarly, results by Koroleva (1988) demonstrated that the
number of lactic acid bacteria tended to increase over time when lesser amounts of kefir
grains were inoculated into the milk.
1.3.1 Microflora
Isolation and identification of the different strains of bacteria and yeasts present in
kefir grains have traditionally been performed using culture-dependent methods, meaning
that the probiotic species must be grown on selective media with identification being based
on morphological and biochemical characteristics (Simova, et. al., 2002 and Wang, et. al.,
2008). However, some studies have shown that many of the strains are very closely related
and may pose problems when trying to isolate and identify individual strains (Micheli, et.
al., 1999; Guzel-Seydim, et. al., 2005).

More recent investigations have attempted to

isolate strains based on genotype using polymerase chain reaction (PCR) combined with
denaturing gradient gel electrophoresis (DGGE) (Wang, et. al., 2008; Tas, et. al., 2012;
Garofalo, et. al. 2015).

This culture-independent identification may be a useful in
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analyzing complex microbial populations because this type of testing does not require prior
separation of individual strains, as in culture-dependent identifications (Ercolini, 2004).
1.3.1.1 Lactobacilli
Lactobacilli are present in the largest amounts (65-85%) of the microbial population
of kefir and kefir grains (Witthuhn, et. al., 2004). In a study examining the microflora of
Brazilian kefir and kefir grains, Magalhas, et. al. (2011) also found lactobacilli species to
be the predominant lactic acid bacteria type (78%) in kefir fermented with kefir grains,
with lactococci comprising the majority of the remaining 28% of lactic acid species.
Magalhas, et.al. (2011) also identified lactic acid bacteria isolates; Lactobacillus paracasei
represented the largest and most commonly identified lactic acid bacteria isolate which
represented 89 of 249 isolates.

This was followed by Lactobacilli parabuchneri (41

isolates), Lactobacilli casei (32 isolates) and Lactobacilli kefiri (31 isolates) (see Table 2).
Table 2. Bacterial species commonly found in kefir and kefir grains.
Lactobacilli
Lactobacillus kefir
Lactobacillus kefiranofaciens
Lactobacillus rhamnosus
Lactobacillus casei
Lactobacillus paracasei
Lactobacillus fructivorans
Lactobacillus hilgardii
Lactobacillus fermentum
Lactobacillus viridescens
Lactobacillus helveticus
Lactobacillus acidophilus
Lactobacillus delbruckii
Lactobacillus brevis
Lactobacillus plantarum
Lactobacillus parakefir
Lactobacilli parabuchneri
Lactobacilli kefiri

Lactococci
Lactococcus lactis subsp. lactis
Lactococcus lactis subsp. cremoris

Acetic Acid Bacteria
Acetobacter aceti
Acetobacter pasteurians

	
  
Streptococci	
  
Streptococci thermophilus	
  
Streptococci durans	
  

	
  
Other
Bacteria	
  
Bacillus subtilis	
  
Micrococcus sp.	
  
Enterococcus durans	
  

	
  
Leuconostocs	
  
Leuconostoc mesenteroides	
  
Leuconostoc kefir	
  
Leuconostoc sp.	
  

(adapted from: Witthuhn, et. al., 2004; Guzel-Seydim, et. al., 2005; Wang, et. al., 2008;
Magalhas, et.al., 2011; Tas, et. al., 2012; Garofalo, et. al. 2015)

9

1.3.1.2 Lactococci
Magalhas, et. al. (2011) was only able to isolate one species, Lactococcus lactis,
from Brazilian kefir and kefir grains; this particular species was identified in all 24
lactococci isolates from the total of 249 lactic acid bacteria isolates. In a 2005 study by
Guzel-Seydim, et. al. a microbial enumeration and electron microscopy was performed on
Turkish kefir and kefir grains, and although long, short and curved lactobacilli and yeasts
were found in all samples, lactococci were not observed in any portion of the kefir grain.
Guzel-Seydim, et. al. (2005) postulated that the presence of lactococci in the kefir but not
in the grain samples might be caused by the unintentional removal of lactococci from the
surface of the grains.
1.3.1.3 Yeasts
Magalhas, et. al. (2011) showed a majority of Brazilian kefir yeast isolates to be
lactose-negative strains; specifically Saccharomyces cerevisiae, which made up 41 of 110
yeast isolates.

Other non-lactose fermenting species isolated included Kazachstania

aerobia (23 isolates) and Lachancea meyersii (15 isolates); these two species had been
previously unreported in kefir and kefir grain studies (see Table 3). Yeasts, such as
Saccharomyces cerevisae, contribute greatly to the sensory qualities of the kefir
beverage, as they promote an alcoholic and yeasty aroma, as well as a refreshing taste
(Magalhaes, et. al., 2011). It is also worth noting that the presence of non-lactose
fermenting yeasts in kefir and kefir grains is dependent on the presence of other lactose
fermenting species of bacteria and yeasts capable of hydrolyzing lactose (Simova, et. al.,
2002).
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Table 3. Species of yeasts reported in kefir grains of various origins.
Saccharomyces cerevisiae
Saccharomyces unisporus
Saccharomyces turicensis
Saccharomyces delbrueckii
Saccharomyces dairensis
Saccharomyces lactic
Saccharomyces spp
Kluyveromyces marxianus
Kluyveromyces lactis

Candida friedrichi
Candida friedrichii
Candida pseudotropicalis
Candida tenuis
Candida inconspicua
Candida maris
Candida lambica
Candida tannotelerans
Candida valida
Candida kefyr
Candida holmii

Torulaspora delbrueckii
Kazachstania aerobia
Brettanomyces anomalus
Lachancea meyersii
Issatchenkia occidentalis
Pichia frementans

(adapted from: Simova, et. al., 2002; Magalhaes, et. al., 2011; Diosma, et. al., 2014;
Garofalo, et. al., 2015)
According to Irigoyen, et. al. (2005), the levels of yeasts and acetic acid bacteria
present in kefir are directly proportional to the quantity of grains inoculated. Interestingly,
their study also found the levels of lactobacilli and lactococci to be inversely proportional
to the amount of inoculate used; therefore, the number of microorganisms was higher when
fewer kefir grains were used. This might be due to a more rapid initial increase in the
amount of lactic acid bacteria in the kefir inoculated with the higher percentage of grains;
the higher number of initial bacteria might cause a quick, sharp drop in pH which would
kill some of the more acid sensitive strains, thus preventing their growth during storage and
allowing for an increased proliferation over time of yeasts and other types of bacteria, such
as micrococci and acetic acid bacteria. It has also been shown that lactic acid bacteria
multiply less rapidly, and therefore, produce lactic and acetic acids more slowly when
incorporated into a mixture containing yeasts than in a pure culture (Collar, 1996).
During refrigerated storage of kefir, lactic acid bacteria will begin to decrease, while
the numbers of yeasts and acetic acid bacteria will remain fairly consistent (Irigoyen, et.
al., 2005). Irigoyen, et. al. (2005) found no significant differences in yeast counts during
a thirty day storage period at approximately 5°C; however, lactobacilli and lactococci
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were shown to be significantly lower after thirty days of storage. These results differ
from a similar study by Guzel-Seydim, et. al. (2005) that examined the microbiota of
Turkish kefir and kefir grains; the microbial counts of the lactic acid bacteria did not
decrease, and actually exhibited continued growth during and after 21 days of
refrigerated storage. This can most likely be attributed to the ability of many of the yeast
species present in kefir to metabolize some of the lactic acid produced by the bacteria,
therefore enhancing the survivability of the lactic acid bacteria by the reduction metabolic
end products.
1.3.2 Kefiran
EPS produced by some lactic acid bacteria have been the recent focus of research in
various food industries as a beneficial additive for increasing viscosity in products, and the
stipulated health benefits associated with bacterial EPS provide an added appeal to the
consumer. Kefiran, an EPS produced and subsequently excreted by a certain strains of
lactic acid producing bacteria found in kefir grains and kefir has been isolated, and its
composition and chemical structure have been determined using methods such as acid and
enzymatic hydrolysis and scanning electron microscopy (Figure 3). Although, at present,
no studies isolating kefiran from the kefir beverage have been reported, Cerning, et. al.
(1999) listed the range amount of EPS produced by lactic acid bacteria in fermented
products as 25 to 890 mg/L.
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Figure 3. Scanning electron microscopy of Brazilian kefir grain microbiota. A, C, E: outer
grain portions, B, D, F: inner grain portions. Arrows - Micrography A: cocci; Micrography
D: fibrillar material - kefiran polysaccharide; Micrography E: arrow 1 - granular material coagulated protein, arrow 2 - different yeast species. (source: De Oliveira Leite, et. al.,
2013: Creative Commons License CC BY-NC)
The structure of kefiran was described by Riviere, et. al. (1967) as a water-soluble
glucogalactan containing roughly equal amount of D-glucose and D-galactose residues.
The production of this EPS is stimulated when L. kefiranofaciens grows in co-culture
with S. cerevisiae, other yeasts and yeast extracts (Cheirsilp et al., 2003; Zajšek, et. al.,
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2013; Pop, et. al., 2014). Lactobacillus kefiranofacians, the kefiran producing strain,
comprises at least 24% of the dry material of the kefir grain. Although the chemical
analysis preformed by Riviere, et. al. (1967) was accurate, the bacterium has, in recent
years, been referred to as Lactobacillus kefir (Frengova, et, al., 2002) and most currently
asLactobacillus kefiranofacians (Cheirsilp, et. al., 2003). However, there are conflicting
opinions in several independent studies regarding the naming of this bacterium and if the
Lactobacillus kefiran and Lactobacillus kefiranofacians are the same strain or two
different strains, with one or both producing kefiran in differing amounts (Kandler, et. al.,
1983; Frengova, et. al., 2002; Rimada, et. al., 2002; Piermaria, et. al., 2009).
Different conditions such as the species present, the ratio of bacteria to yeasts,
fermentation time, incubation temperature, storage time and other conditions can all
affect the amount of EPS produced by kefiran producing strains (van Geel-Shutten, et.
al., 1998). Mozzi, et. al. (1995) found that by increasing the time of fermentation up to
72 hours a significant reduction in kefiran synthesis was observed; these results were
dependent both on the fermentation temperature (30, 37 and 42°C) and the strain of lactic
acid bacteria employed.
The activity of the grains, or more precisely, the activity of the kefiran producing
strains also plays a major role in the amount of kefiran present in the product. Schoevers,
et. al. (2003) has reported a lowering of lactobacilli species present, as well as cellular
activity, in some the kefir grains that have been subjected to prolonged storage without
fresh milk or exposure to widely varying environmental conditions, such as fluctuating
incubation temperatures or a change in milk type.
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Because other environmental conditions such as temperature, pH, carbon and
nitrogen content influence EPS production, control of fermentation protocols are
important. Zajšek, et. al. (2013) established the optimal fermentation temperature to be
30°C, where EPS production from the kefir grains was maximal. Some yeast species
present are also able to metabolize some of the lactic acid produced by the bacteria,
therefore enhancing the survivability of the lactic acid bacteria by the reduction metabolic
end products. EPS similar to kefiran have also been isolated, although in lesser amounts,
from other lactic acid species such as Lactobacillus reuteri and Lactococcus lactis ssp.
cremoris (van-Geel Schutten, et. al., 1998; Yang, et. al., 1999; Patel, et. al., 2012). Other
examples of EPS use in the food industry are xanthan produced by Xanthomonas
campestris and gellan from Pseudomonas eloda (Matsukawa, et. al., 2007; Patel, et. al.,
2012).
1.4 Physiochemical and Sensory Properties of Kefir
The major end products, according to Kooman (1968), are approximately 0.8%
lactic acid, 1.0% ethyl alcohol and carbon dioxide. Also present in smaller amounts are
acetic acid, numerous volatile flavor compounds such as diacetyl and acetylaldehyde,
exopolysaccharides, organic acids, and various vitamins and minerals. The optimum taste
profile in kefir has a 3:1 diacetyl to acetylaldehyde ratio with a pH of 4.6 using milk with
an initial fat content of no less than 3.0%, and although complex alcohols and acetone have
also been identified as end products, they are not thought to be predominant factors in the
flavor profile (Kosikowski, et. al., 1997; Kakisu, et. al., 2011).
The fat content of kefir may range from 0.5 to 3.0 percent, with solids not from
fat from 8.0 to 11.0 percent (Kosikowski, et. al., 1999). This includes approximately
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2.0 g of lactose per 100 g of kefir; the fermentation of milk by kefir grains results in
approximately a 30% reduction in lactose (Alm, 1980). Alm (1980) examined lactose
intolerant individuals demonstrating symptoms of abdominal distress and diarrhea
following consumption of 500 ml of low fat milk and found that of the same quantity of
fermented milk did not result in any symptoms.
The fat content of kefir will vary depending on the original fat content of the milk
used (whole vs. skim, bovine vs. caprine), and the action of the microflora on milk fat can
have significant effects on the lipid profile, especially after storage for a brief period
(Gul, et. al., 2015). In a study involving the physiochemical analysis of milk, Irigoyen,
et. al. (2005) found that the fat content of the finished kefir did not differ significantly
from the fat content of the milk that the kefir was made from; however, oxidation of the
fat molecules and the off-flavors associated with lipid oxidation can be counteracted to
some degree by the microorganisms in kefir (as well as other fermented milks). The
lactic acid bacteria consume oxygen providing a reducing effect, and during storage
lipolysis, the breakdown of fats into glycerol and free fatty acids will also occur,
contributing to an increase in short chain fatty acids (SCFA) (Alfa-Lavel, 1987).
Flavors attributed to higher levels of SCFA in milk can be very influential on
flavor profile of fermented milks. For example, the release of capric acid, the most
abundant saturated fatty acid found in goat milk, from the triglyceride will result in a
distinctive goat milk flavor, often characterized as a “goaty” or “musky” flavor. The
yeasts involved in kefir fermentation, particularly Saccharomyces cerevisiae, are also of
importance when characterizing the sensory qualities of the kefir beverage, as they
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promote a strong and typically yeasty aroma, as well as a refreshing and pungent, slightly
alcoholic taste (Magahlaes, et. al., 2010).
1.5 Kefir Production Methods and Consumer Preferences
During kefir manufacture with the grains, the lactic acid fermentation slows
considerably or stops as the pH declines, but the yeast fermentations continue allowing
for an increase in ethanol production during storage. The secondary alcohol fermentations
can lead to substantial changes in flavor as well as bulging or leaking packaging due to
the continued production of carbon dioxide gas (Kwak, et. al., 1996; Sarkar, 2008).
Commercial kefir production utilizes a dry starter culture typically consisting of
8-12 species of bacteria and yeasts isolated from lyophilized kefir grains (or other
sources). A new commercial starter, whether dry or from a liquid mother culture, must
be added to each new batch of milk for kefir production. Studies preformed by Simova,
et. al. (2002) demonstrated that traditionally produced kefir (with the starter grains
removed) could not be used as a starter culture for kefir. The primary drawbackfor the
large scale manufacture and marketing of traditionally produced kefir is that secondary
alcohol fermentation often occurs at the distribution and storage phases, resulting in
changes in flavor and taste because of the continued formation of ethanol and carbon
dioxide gas (Kwak, et. al., 1996). This can result in swollen and leaking containers as the
excess gas increases the internal pressure of the container and inconsistences in the final
products.
A study by Beshkova, et. al. (2002) showed and increase in ethanol from 0.25% in
traditional to 0.48% in commercial kefir, and an increase in CO2 of 1.05g/l to 1.98 g/l.
Kwak, et. al. showed that biostabilization of kefir can be achieved by using a starter
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culture in which non-lactose fermenting yeasts, such as Saccharomyces cerevisiae, are
present in substantial numbers.

In fact, the standardization of the production of flavor

compounds including lactic acid and ethanol has been achieved, for the most part, by the
utilization of pure cultures as a starter for the commercial production of kefir.
Gronnevik, et. al. (2011) showed that the levels of lactic acid and ethanol in Norwegian
commercial kefir remained consistent during an 8-week storage period, with some
volatile compounds fluctuating slightly; this was probably due to an increase in the yeast
metabolism of bacterial intermediate or end products. This can be compared to studies
performed on the physicochemical changes in milk during the production and storage of
traditional kefir, which were found to be in flux and somewhat inconsistent between kefir
made from differently sourced grains (Wszolek, et. al., 2001; Chen, et. al., 2005;
Irigoyen, et. al., 2005; Magalhaes, et. al., 2011). The development of commercial starter
cultures has allowed for widespread distribution of kefir and kefir products; however, the
demand for traditionally produced kefir is rising, and methods for producing a consistent
product with an adequate shelf life are being developed.
1.6 Health Benefits of Probiotics and Kefir
Similar to other fermented dairy foods supplemented with probiotic bacteria,
health aspects attributed to the consumption of kefir include, but are not limited to,
improved lactose utilization, anti-carcinogenic activity, control of intestinal infections
and improved nutritional quality of the milk (Figure 4).
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Figure 4. Proposed health benefits associated with the consumption of probiotics.
(source: Anandharaj et al., 2014; distributed under the Creative Commons Attribution
License)
In order for a probiotic to benefit human health it must have good technological
properties, survive through the upper gastrointestinal tract and be able to function in the
gut environment (Mattila-Sandholm, et. al., 2002). These properties, as well as many
health benefits, have been examined, and kefir has demonstrated a wide array of positive
effects such as antitumor and immunostimulating activity in animals (Quiros, et. al.,
2005; Ghoneum and Gimzewski, 2014); these effects are only seen when the probiotics
ingested are functioning properly in the intestinal mucosa (Figure 5).
Prebiotic and probiotic benefits incurred by the consumer include: competitive
exclusion of pathogenic bacteria, increased absorption of nutrients, and well documented
immunomodulating effects, such as the modification of the balance of immune cells in
the intestinal mucosa (Vinderola, et. al., 2006; Maalouf, et. al., 2011; Medrano, 2011)
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(see Figure 5). Probiotic organisms can exert their beneficial properties through two
mechanisms: direct effects of the live microbial cells (probiotics) or indirect effects via
metabolites of these cells (biogenics) (Vinderola, et. al., 2004). Biogenics are defined as
food components that are derived from microbial activity which provide health benefits
without involving the intestinal microflora (Takano, 2002).

Figure 5. Effects of probiotic bacteria and yeast on intestinal epithelial barrier function.
(source: Ohand, et. al., 2010: https://s100.copyright.com/AppDispatchServlet#formTop)
Several strains of Lactobacillus delbrueckii and Streptococcus thermophilus
produce EPS (Hong and Marshall, 2001).

In kefir, these loosely bound

exopolysaccharides couls act as a stabilizer, preventing syneresis and graininess and
provide a natural thickening effect (Cerning, 1990).

In regards to health, bacterial

exopolysaccharides could provide benefits such as aiding in bacterial adhesion to the
lining of the gut and protection of probiotics during transit though the gastrointestinal
tract.
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Because the origins of lactic acid bacteria and yeasts are not human associated,
they can be sensitive to the harsh conditions of the stomach and bile acids. This aspect
becomes president when considering the health benefits incurred by the consumer of
probiotic containing products. It has been shown that both the strain and the amount of
probiotic species play a role in determining survival in the human gut (Elli, et. al., 2006
and Conway, et. al., 1987); and the adhesion to intestinal epithelial cells may play a
critical role in the immunostimulating and immunomodulating effects of certain probiotic
species. However, in vivo adhesion will most likely be influenced by both the normal
microbiota and the specific probiotics included, but only few studies to date have directly
examined the adhesion interactions of the probiotics and the intestinal mucosa
(Ouwehand, et. al., 2000 and Collado, et. al., 2007).
In addition to the immunostimulating benefits of probiotics, kefir exhibits
additional biological activities that include antibiotic and antifungal properties
(Farnsworth, et. al., 2003); antioxidant action of probiotic bacteria towards numerous
human pathogens has been also been observed in several studies (Zacconi, et. al., 2003;
Medrano, et. al., 2006; Ismaiel, et. al., 2011).

In a 2004 study, Rodrigues, et. al.

demonstrated the antimicrobial and healing activity of kefir and kefiran extract; they
showed that successful and faster wound healing occurred in rats when a topical kefiran
mixture was used as alternative to antibiotics. Other studies have demonstrated that
antibacterial, antimycotic and antitumor activity of cells increase when exposed to kefir
and kefiran (Garrote, et. al., 2004; Micheli, et. al., 1999; Frengova, et. al., 2002).
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1.7 Physiological Effects of Endurance Exercise
1.7.1 Metabolic Effects
Endurance exercise depletes the body’s glucose stores (blood glucose, muscle and
liver glycogen) and can have a catabolic effect on muscle proteins immediately following
exercise. To most efficiently replenish energy stores and to maintain the functioning of
skeletal muscles, adenosine triphosphate (ATP) is produced via the oxidative
phosphorylation of carbohydrates, proteins and fats, as seen in Figure 6. During moderate
physical activity intracellular glycogen and free fatty acids are the primary substrates
utilized in the oxidative pathway; however, for endurance athletes, circulating glucose
also provides a significant ATP source when exercising for prolonged periods of time

Glucose and Free Fatty Acid
Apperance Rates
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Figure 6. Rates of appearance of circulating glucose and free fatty acids (FFA) during
exercise at graded intensities in humans. VO2max: maximum oxygen uptake. (modified
from: De Feo, et. al., 2003).
It has been well established that exercise can be a key strategy for improving
health and is actually essential for good metabolic and cardiovascular function, of which
insulin action is a primary component (Thyfault and Krogh-Madsen 2011), and the
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beneficial effects of high intensity exercise have been demonstrated in several controlled
studies (Babraj, et. al. 2009; Little, et. al. 2011). In order to optimize the metabolic,
cardiovascular and psychological benefits that exercise can offer, Garber, et. al. (2011)
advises people to perform a large volume (at least 30 min per day) of both moderate and
vigorous intensity cardiorespiratory exercise on most days of the week, as well as
strength and flexibility sessions 2–3 times per week. However, Metcalf, et. al. (2012)
demonstrated that shorter and more intense exercise sessions could infer beneficial
effects as well by conducting a 6-week exercise intervention consisting of very brief,
manageable sessions; results showed that a short exercise intervention was associated
with improved insulin sensitivity in sedentary young men, and improved aerobic capacity
in men and women.

When describing normal metabolic responses of individuals

following exercise, differences between men and women must also be considered. By
following a traditional aerobic exercise intervention in a large cohort, Boule, et. al.
(2005) demonstrated that insulin sensitivity improved to a greater degree in men when
compared with women, but the female participants had a higher baseline level of insulin
sensitivity which may, in turn, impact subsequent metabolic training responses.
1.7.2 Immune Functioning
Prolonged intense exercise often results in perturbations in cellular aspects of
immunity. Strenuous and eccentric exercise seems to exert the most prominent changes
in immune parameters with extreme exercise, such as marathons and other frequently
used training programs, being associated with a depression in immune function
(Fitzgerald, 1991). In a 1992 study Keast, et. al. determined that regular, moderate
training does seem to promote resistance to upper respiratory tract infection (URTI);
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however, severe exertion, especially when coupled with mental stress, places athletes at
increased risk for URTI (Nieman, 1994). A limitation to these types of epidemiologic
studies on exercise and URTI is that they are based on self-reported symptoms rather than
clinical verification and can often be unreliable (Hoffman-Goetz, et. al., 1995). Figure 7
shows the link between exercise associated immune changes and sensitivity to infection
that may be explained by the so-called “open window” of altered immunity (Pederson
and Toft, 2000).

Figure 7. Model of the proposed neuroendocrinological mechanisms underlying the
exercise induced “open window” in the immune system. (modified from: Pedersen and
Toft, 2000).
Many of the mechanisms underlying exercise associated immune changes are
multifactorial and include important neuroendocrinological factors such as adrenaline
(epinephrine),

noradrenaline

(norepinephrine),

growth

hormone,

and

cortisol

(Newsholme, 1994). The concentrations of these hormones typically increase during
exercise and return to original values shortly after, but they also seem to exert effects on
lymphocytes and neutrophils during the recovery period. Pederson and Toft (2000)
hypothesized that during the first few hours following exercise, when immune
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suppression is most pronounced, viruses and bacteria may gain a foothold, increasing the
risk of subclinical and clinical infection.
1.7.3 Inflammation
Chronic inflammation is theorized to be the root cause for a number of associated
diseases and disorders, such as chronic obstructive pulmonary disease, asthma, chronic
heath failure, rheumatoid arthritis, diabetes mellitus type 1 and 2, inflammatory bowel
disease (e.g., Crohn’s disease, ulcerative colitis), inflammatory myopathies (e.g.,
idiopathic, polymyositis, dermatomyositis, inclusion body myositis), juvenile idiopathic
arthritis and multiple sclerosis (Abbas, et. al., 2007; Ploeger, et. al., 2009; Hotamisligil,
et. al., 2006). It has been theorized that the combination of an impaired immune response
coupled with persistent immune stimulation may have a role in the low-grade systemic
inflammation and altered cytokine balance, which may translate into increased
cardiovascular diesase (CVD) risk (Stenvinkel, et. al., 2005; Adamopoulos, et. al, 2001).
Altered levels of cytokines are not only seen in inflammatory diseases; acute and
chronic exercise can also have an effect on cytokine responses and inflammation in
healthy individuals (Ploeger, et. al., 2009). Superficially, the body reacts to physical
activity as it does during an acute, subclinical inflammatory response to a perceived
pathological insult (Ostrowski, et. al., 1998), and pro- and anti-inflammatory cytokines
are released into the circulation (Northoff, 1994).
The effects of regular or chronic exercise on basal levels of inflammatory markers
have been used to recommend exercise as an anti-inflammatory therapy (Adamopoulos,
2002). However, compared to acute bouts of exercise, the effects of chronic exercise on
inflammatory markers have been less investigated. Whereas exercise of moderate
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intensity is associated with anti-inflammatory effects (Bruunsgaard, et. al., 2005),
strenuous exercise can affect resting levels of inflammatory markers during and after a
period of intensive training (Gleeson, et. al., 2006; Gokhale, et. al., 2007). In spite of the
different backgrounds and symptoms related to the various diseases, all systemic chronic
inflammation shares common characteristics, including elevated circulating levels of
cytokines tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) under basal or
resting conditions (Hotamisligil, 2006).
1.8 Biological Measures of Inflammation and Immune Functioning
The immune system’s first lines of defense against microbial invasion are the
external secretions that bathe mucosal surfaces (respiratory, intestinal and reproductive);
secretory immunoglobulin A (sIgA) is a key component and is the dominant
immunoglobulin present in mucosal secretions (King, et. al., 2003). IgA is secreted by
mucosal plasma cells that are adjacent to the salivary glands; once secreted from the cell
the dimeric IgA it is bound and transported by a polymeric immunoglobulin receptor
through the salivary cells (King, et. al., 2003). The IgA dimer forms a complex with a
fragment of the polymetric immunoglobulin receptor polypeptide and is released into the
saliva as secretory IgA. Studies have shown that sIgA levels vary in response to stress,
mood and emotional state (Cohen, et. al., 2003).
TNF-α, also known as cachectin, is a non-glycosylated polypeptide cytokine that
is produced primarily by activated macrophages with a large percentage of TNF-α
production being the result of stimulation of macrophages by lipopolysaccharide
(Beutler, et. al., 1895). Therefore, TNF-α becomes an important mediator of the in vivo
effects of lipopolysaccharide, and the inhibition of lipoprotein lipase and apidocyte gene
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expression, in regards to metabolic activities, is strongly influenced by TNF-α (Dinerello,
et. al., 2003). TNF-α is involved in various biological activities such as
immunomodulating and proinflammatory activities by regulation of the production of
antibodies by B cells and stimulation of cytotoxic T cells (Moldoveanu, et. al., 2000).
Since TNF-α has also been shown to increase ubiquitin gene expression in skeletal
muscle, it is possible that it causes muscle wasting by stimulating protein catabolism via
the ubiquitin proteasome pathway (Stenvinkel, et. al. 2005). In a 2000 review, Shek and
Shepard stated that strenuous exercise-induced elevations in interleukin-1β and TNF-α
have been reported, but results from different studies appeared inconsistent, possibly due,
in part, to differences in experimental design, timing of blood sampling, and cytokine
assay sensitivity (Thomson, 1998; Adampopoulos, et. al., 2001; Himmerich, et. al.,
2006).
C-reactive Protein (CRP) is formed primarily in hepatocytes with its rate of
synthesis being primarily influenced by the cytokines involved in inflammatory
processes, and because its half-life is estimated to be rather short (13-16 hours), serum
CRP concentration can reflect acute infection, pneumonia and myocardial infarction
(Cohen and Cohen, 2006). Several recent studies have demonstrated an association
between inflammatory reactions and CVD such as both latent and chronic infections and
arteriosclerosis. In fact, the CRP values found in Table 4 are often used by clinicians to
assess systemic inflammation and are most notably used as a risk factor for CVD (Zulet,
et. al., 2006). However, because no accepted normal ranges for adult populations have
been established, CHD-Risk Level is used as a predictive measure only (Pearson et. al.,
2003).
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Table 4. CRP concentration in plasma and correlated risk of coronary heart disease.
C-Reactive ProteinConcentration for Plasma
< 1 mg/l
1-3 mg/l
> 3 mg/l

Coronary Heart DiseaseRisk Level
low
medium
high

(modified from: Pearson, et. al., 2003
1.9 Sport Nutrition
According to the American College of Sports Medicine (ACSM) (2009), athletes
should consume enough energy during periods of high-intensity and/or long-duration
training in order to maintain body weight and health and to maximize training efforts.
ACSM (2009) reports that low energy intakes can result in loss of muscle mass,
menstrual dysfunction, loss of or failure to gain bone density, an increased risk of fatigue,
injury and illness, and a prolonged recovery process.

Recommendations include a

carbohydrate intake of approximately 1.0-1.5 g per kg body weight during the first 30
minutes after exercise and again every 2 h for 4-6 h in order to adequately replace
glycogen stores (ACSM, 2009) (Table 5).
Table 5. Macronutrient recommendations for athletes following exercise.
Intake (per kg body weight) Intake (per lb body weight)
Carbohydrate*
1.0-1.5 g
0.5-0.7 g
Protein
0.4-0.7 g
0.2-0.4 g
(adapted from: ACSM, 2009)
During exercise, carbohydrates maintain blood glucose levels and replace muscle
glycogen. The ACSM carbohydrate recommendations for athletes range from 6 g/kg to
10 g/kg body weight (Table 5). The amount required depends on the athlete's total energy
expenditure, type of training, sex, and other environmental conditions, such as extreme
heat or cold.

In an article examining the upper and lower limits of carbohydrate

requirements for different types of athletic training, Jeukendrup (2013) concluded that
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carbohydrate needs can reach much higher values (up to 90 g/h) for elite athletes
exercising at higher absolute intensities or during an event lasting more than 2 hours.
Protein intake sufficient to maintain and increase muscle mass is necessary for
optimal health and performance. Protein recommendations for endurance and strengthtrained athletes range from 1.2-1.7 g/kg body weight (0.5-0.8 g/lb body weight).
Consumption of protein provides essential amino acids required for the synthesis of body
proteins. Amino acids also play key roles in the metabolic processes of many organs and
tissues by serving as precursors and regulators in the production of metabolic mediators
and compounds with regulatory biological activity e.g. hormones, neurotransmitters,
DNA and RNA (Jeukendrup and Gleeson, 2010).
Fat is also important in the diet of athletes, not only as a source of energy, but
because it provides fat-soluble vitamins and essential fatty acids. The ACSM (2009)
recommends a fat intake ranging from 20-35% of the total energy intake and goes on to
state that consuming less than 20% of energy from fat does not benefit performance.
Adequate fluid intake before, during, and after exercise is critical for health and
optimal performance to avoid dehydration, with a goal of drinking enough fluid to avoid
dehydration but not in excess of the sweating rate. For fluid intake following exercise the
ACSM recommends 16-24 oz (450-675 mL) of fluid for every pound (0.5 kg) of body
weight lost during exercise.
Before exercise, a meal or snack should provide sufficient fluid to maintain
hydration and ease of digestion and be relatively low in fat and fiber in order to facilitate
gastric emptying and to minimize gastrointestinal distress. The food consumed should be
relatively high in carbohydrates to maximize maintenance of blood glucose, moderate in
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protein, be composed of familiar foods, and be well tolerated by the athlete (ACSM,
2009). The recommendation of the ACSM for nutrition during exercise is for athletes to
replace fluid losses and provide carbohydrates at a rate of approximately 30-60 g/hour
(ACSM, 2009). Following exercise, ingestion of enough fluids, electrolytes and
carbohydrates to replace muscle glycogen will ensure rapid recovery, and protein
consumed after exercise will provide essential amino acids needed for repair and building
of muscle tissue (Maguhan, 1997). Numerous studies have shown a 4 to 1 ratio of
carbohydrates to protein to be the most beneficial macronutrient profile of a recovery
food for athletes (Karp, et. al., 2008; Roy, et. al., 2008; Thomas, et. al., 2009). The
effects of certain foods on intestinal health and overall well being of athletes in reducing
and preventing elevated inflammatory response and instances of suboptimal immune
functioning, as seen by measuring specific markers such as CRP, are also very important
variables to consider for proper sports nutrition.
1.10 Probiotics and Exercise
Elevating and maintaining high levels of stress on the body, as often occurs with
exercise, can cause acute and chronic disruption of immune functioning (Gleeson, et. al.,
2006). In a review examining the relationship between probiotics and exercise, West, et.
al. (2009) concluded that probiotic supplements modulate the intestinal microbial flora
and offer promise as a practical means of enhancing gut and immune function in athletes.
Studies involving probiotics and athletes have demonstrated maintenance of
gastrointestinal (GI) function and health by reducing the frequency and severity of GI
issues including cramps, nausea, bloating and diarrhea during and following exercise
(Berg, et. al., 1999). Attenuation of immunosuppressive effects of exercise have also
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been demonstrated in athletes receiving an encapsulated probiotic supplement during
training (Bishop, et. al., 2009). A similar study conducted by Kekkonen, et. al. (2007)
showed a reduced susceptibility to illness especially in regards to an enhanced resistance
to upper URTI in athletes consuming probiotics.
Zonulin is a novel protein that modulates intestinal permeability by disassembling
the intercellular tight junctions (TJs) (Wang, et. al., 2001). This protein is most likely
involved in the innate immunity of the gut and, when upregulated, appears to play a key
role in the pathogenesis of autoimmune diseases, such as celiac disease (Sapone, et. al.,
2006). Reduced gut permeability in athletes receiving a probiotic supplement during the
course of a 14-week intensive cycling training course was demonstrated by a significantly
lowered amount of zonulin in the feces of the probiotic group as compared to the placebo
indicating reduced gut permeability in the probiotic supplemented group (Lamprechet, et.
al., 2012).

In addition, Lamprechet, et. al. (2012) concluded that probiotic

supplementation beneficially affected TNF-α and exercise induced protein oxidation.
Many probiotic strains are also able to stimulate the production of IgA by B cells, which
help maintain intestinal humoral immunity by binding to antigens, thereby limiting their
access to the epithelium (Delcenserie, et. al., 2009).
1.11 The Role of Dairy Foods in Sport Nutrition
Milk, supplemented with the recommended amount of carbohydrate, has been
shown to be an ideal recovery beverage for athletes following bouts of resistance and
endurance training as a way to attenuate some of the acute affects of strenuous activity
(Roy, et. al., 2008; Thomas, et. al., 2009). In a 2007 study, Wilkenson found that milk-
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based proteins promote muscle protein accretion to a greater extent than do soy-based
proteins when consumed after resistance exercise.
The U.S. Department of Agriculture and U.S. Department of Health and Human
Services 2010 Dietary Guidelines for Americans recommends milk as a healthful, protein
and nutrient rich food source for people of all ages and activity levels. Milk is also a good
source of calcium, phosphorous, vitamin D, riboflavin, and potassium (NIH, 2013).
These nutrients play key roles in the development of strong bones and in restoring proper
electrolyte balance and rehydration following exercise.
Although can milk play an important role in sport nutrition, athletes with lactose
sensitivities are unable to consume lactose containing dairy products, such as
unfermented milk, without some degree of gastrointestinal discomfort. The production of
lactase by mucosal cells in the intestinal epithelium decreases with age in most humans,
particularly in individuals of East Asian and African descent (Suchy, et. al., 2010), and it
is estimated that 65% to 85% of adults of these races lack sufficient lactase to digest the
lactose that would accompany the Dietary Guidelines for American’s recommended 3
servings per day of low-fat dairy products (Heaney, 2013).

According to a cross

sectional diagnostic study performed by Srinivasan, et. al. (1998), the highest rates of
lactose malabsorption were found in Asian populations, Native Americans and African
Americans (60–100%) and lowest rates in people of northern European origin and the US
white population (2–22%).
It is the absence of adequate hydrolysis of lactose in the small intestine (where the
enzyme is normally active) that results in the passage of undigested lactose into the distal
bowel where bacteria ferment the sugar, sometimes producing gas and symptoms such as
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cramps, bloating, flatulence, and diarrhea (Tomba, et. al., 2012).

When lactose

malabsorption gives rise to symptoms, this is called ‘lactose intolerance’. However,
because a large portion of the lactose (≥30%) in milk is metabolized by lactic acid
bacteria in the kefir culture, symptom free consumption of the kefir beverage by
individuals with lactose sensitivities is possible, allowing milk to be a healthful addition
to the diet.
In addition to the many beneficial nutrients intrinsic to the milk itself, healthful
properties acquired by kefir during fermentation could be of importance to athletes, such
as an increased bioavailability of the protein in milk (Magalhaes, et. al., 2011) and an
enhanced micronutrient profile (Farnworth, 2003). In addition, several studies have
shown the large amounts of medium and short chain fatty acids found in fermented milk
are to aid in digestion and utilization of lipids (Kalser, 1971; Babayan, et. al., 1981; Fathi,
et. al., 2015).
The capacity for probiotics to modulate perturbations in immune function after
exercise highlight their potential for use in individuals exposed to high degrees of
physical stress (West, et. al., 2009). The increased biomass of the microbes and the
production of cellular proteins, peptides and free amino acids, that are subsequently
released into the kefir beverage, further enhance the digestibility of milk and would make
a kefir recovery beverage a good source of nutrients required for muscle synthesis and
regeneration following activity.
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1.12 Objectives
The objectives of this project were to:
1. Design an all natural, minimally processed post-exercise kefir based recovery
beverage for athletes that meets 3 specific criteria: (1) follows the ACSM guidelines
for endurance athlete nutrition following exercise, (2) has a significantly reduced
lactose content to allow for consumption by lactose sensitive athletes, (3) contains
live, active probiotic cultures at the time of consumption.
2.

Determine the physiological responses to intensive exercise training and kefir
supplementation by examining levels of established biological markers of
inflammation and immune functioning

3. Provide sensory and product survey components implementing both affective and
descriptive methodologies to (1) provide insight into the role of nutrition in exercise
and current dietary practices in college students and student athletes, especially as
they relate to dairy foods, (2) assess the current recovery protocols being
implemented by the participants, (3) quantify participant consumption of fermented
dairy products, (4) collect sensory data that can be used to further refine the
formulation of the product with emphasis on acceptability post-exercise.
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CHAPTER 2. MATERIALS AND METHODS
2.1 Experimental Design
A kefir beverage and a control beverage were administered in isocaloric amounts
to 4 treatment groups: exercise training group supplemented with a non-fermented
control beverage (n=11), exercise training group supplemented with a probiotic kefir
beverage (n=14), active control supplemented with a non-fermented control beverage
(n=21) and active control supplemented with a probiotic kefir beverage (n=21) (Table 6).
Table 6. Treatment group and sample size for subjects participating in a 15-week
marathon training program and receiving a supplemental recovery beverage.
Subject Group
Exercise Training Control (ETC)

Treatment 1:
Exercise
Exercise Training

Treatment 2:
Kefir
Control Beverage

Sample
Size
n=11

Exercise Training Kefir (ETK)

Exercise Training

Kefir Beverage

n=14

Active Control Control (ACC)

Active Control

Control Beverage

n=21

Active Control Kefir (ACK)

Active Control

Kefir Beverage

n=21

Throughout the intervention period, all subjects in all four groups completed
weekly sickness, burnout, training/injury logs, diet records and sensory questionnaires
relating to the beverages. Baseline measurements including height, weight, skinfold
measurements and physical activity assessments were taken for all study participants.
Subjects also were required to complete a 1.5-mile walk/run in the fastest possible time
(Figure 8). Venus whole blood and plasma/serum samples (10 mL per sample) (20 mL
total) were collected at the beginning (Pre) and at the end (Post) of the intervention
period and were analyzed for levels of CRP, TNF-α and sIgA. This project was approved
by the Louisiana State University Institutional Review Board (appendix A).
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Pre-intervention tests
Baseline resting measurements
Blood collection
Diet log
1.5-mile walk/run

Post-intervention tests
Baseline resting measurements
Blood collection
Diet log
1.5-mile walk/run

Exercise Training + Kefir Beverage (ETK)
Exercise Training + Control Beverage (ETK)
I----------------------------------------15 week intervention ----------------------------------------I
Active Control + Kefir Beverage (ACK)
Active Control + Control Beverage (ACC)
Figure 8. Experimental design
2.2 Product Development
A kefir beverage and a control beverage were developed to meet the ACSM
guidelines for recommended nutrition following endurance and resistance exercise. All
products were manufactured, packaged and stored at the Louisiana State University
Creamery (123 Dairy Science Building, Louisiana State University, Baton Rouge).
2.2.1 Fermented Milk Beverage
Pasteurized, non-homogenized, full fat cow’s milk was fermented in either gallon
sized lidded glass containers or 5 gallon lidded stainless steel milk pails by inoculation
with approximately 30 grams of kefir grains (Cultures for Health, Sioux Falls, SD) per
gallon of milk. During the fermentation process, the kefir grains were contained in
unbleached cotton tea bags (Figure 9). The bags were sterilized in boiling water before
addition of the kefir grains. The milk was allowed to ferment at 25°C for approximately
24 hours, or until a pH of 4.6 was reached. The kefir was then placed in refrigerated
storage until formulation and packaging of the beverage.
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The fruit base for the kefir beverage was processed separately and was
subsequently blended with kefir several hours prior to consumption by the study
participants. The fruit base included all ingredients, except the dairy portion; it was
prepared using a VitaMix Commercial/Household Food Preparing Machine Model
VM0100A. After combining the kefir and the fruit base, sixteen ounces of the product
were portioned into clear plastic containers with snap on lids with a tamper evident seal.
Each container was labeled with a number that corresponded to a coded system indicating
the intended date of consumption and manufacture date. The containers were placed in
refrigerated storage (6±5°C) until consumption. No other identifying information was on
the container when presented to the participants.
2.2.2 Control Beverage
The non-fermented milk beverage was made using a VitaMix Commercial and
Household Food Preparing Machine Model VM0100A. Lactaid®, an ultra-pasteurized
homogenized lactose-free milk product, was used as the dairy portion of the control
beverage.
The fruit base for the control beverage was processed separately and was blended
with Lactaid® several hours prior to consumption by the study participants. The fruit base
included all ingredients except the dairy portion; it was prepared using a VitaMix
Commercial/Household Food Preparing Machine Model VM0100A. After combining the
Lactaid® and its fruit base, sixteen ounces of the product were portioned into clear plastic
containers with snap on lids with a tamper evident seal. The filled containers were placed
in refrigerated storage (6±5°F) until consumption. Each container was labeled with a
number that corresponded to a coded system indicating intended date of consumption and
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manufacture date. No other identifying information was on the container when given to
the subjects for consumption.
2.2.3 Quality Control Testing
To ensure the microbiological safety of the product 1 ml of each batch of the
finished kefir was plated on E. coli/coliform Petrifilm™ (3M, St. Paul, WI); each batch
of the fruit base was also tested. Finally, each batch of the final kefir beverage and the
final control beverage was tested by plating 1 ml of the prepared products on E.
coli/coliform Petrifilm™.

The petrifilm was incubated aerobically at 32°C for

approximately 24 hours. All beverages consumed by the participants had a coliform
count of <1 cfu/ml. The percent titratable acidity (0.80±0.04 %) and pH (4.43±0.06) of
each batch of kefir used in the kefir beverage was also assessed to ensure consistency of
the finished product.

Lactose levels in the kefir were determined using the

Enzymatic/UV method (r-biopharm AG, Darmstadt, Germany). Percent lactose in the
kefir was 3.49-3.56 % w/w, indicating a 30% reduction of lactose during fermentation.
Quality control testing was conducted in the Dairy Science Laboratory (119 Dairy
Science Building, Louisiana State University, Baton Rouge).
2.2.4 Nutritional Analysis
The nutrient profiles of the kefir beverage and the control beverage were identical
and described in Table 7.
Table 7. Nutrient profile of recovery beverage given to endurance athletes participating in
a 15-week marathon training program and an active control.
Serving size
(ounces)

Calories
(kcal)

Fat (g)

Sodium
(mg)

16
12

220.16
165.12

5.4
4

71.68
53.76

Total
Carbohydrate
(g)
66.56
50
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Fiber
(g)

Sugar
(g)

Protein
(g)

2.8
2

30.72
23.04

10.24
7.7

Nutritional analysis for the products and ingredients was performed using The
Food Processor® Nutrition and Fitness Software (ESHA Research, Professional
Nutritional and Analysis Software, Salem, OR).

Macronutrient contents for each

ingredient were generated by The Food Processor® software and the total macronutrient
composition for each beverage was calculated from those values (Table 8 and Table 9).
Table 8. Composition of a kefir beverage given to endurance athletes and an active
control during a 15-week marathon training program. Weights, nutrients and probiotics
are reported as mean values.
8

9

Bacteria (Lactobacillus, Lactococci, Streptococci)

10 -10 cfu/g

Yeasts

10 -10 cfu/g

Kefir
Honey
Strawberries
Banana
Vanilla3extract
Stevia

Weight
672
72
128
354
13
>1

Calories
Fat
448.5
219
46
315
37
0

Batch3total
Per3gram
Serving3(123oz)
Serving3(163oz)

1239
1
192
256

1065.5
0.86
165.12
220.16

25
0
0
1
0
0

6

7

Sodium
Total33Carbs Fiber
338.5
34.5
3
225
1
10
3.5
56
1
1.5
0
0

26
0.021
4
5.4

347
0.28
53.76
71.68

327
0.26
50
66.56

Sugar

Protein

0
1.8
3
9
0
0

34.5
60
6
43
1.5
0

26
0
1
3.5
0
0

13.8
0.011
2
2.8

145
0.12
23.04
30.72

30.5
0.04
7.7
10.24

Table 9. Composition of a control beverage given to endurance athletes and an active
control during a 15-week marathon training program. Weights, nutrients and probiotics
are reported as mean values.

2.3 Subject Recruitment
The marathon training group was recruited from a Louisiana State University
class, Kinesiology 4526: The Physiology of Endurance Training. The instructor of this
course was Laura Stewart, Ph.D. In addition to traditional coursework, the students
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enrolled in this class were training for a marathon and completing the below
measurements as part of the course requirements. Students interested in joining the
training group portion of this study were asked after the KIN 4526 class period if they
would allow us to use data collected in the class for research purposes. Students were not
penalized for not participating in the study. While there was 100 percent participation by
the students in this course, any students who chose not to participate in this research
study were offered an alternate assignment for course credit. The participants in this class
were assigned randomly into two beverage treatment groups (ETC and ETK).
The subjects for the active control groups were recruited from a Louisiana State
University sanctioned class, Kinesiology 3515: The Physiological Basis of Activity, also
taught by Laura Stewart, Ph.D. The subjects in the active control group were randomly
assigned to their beverage groups (ACC and ACK).
All subjects passed a required health screening and were between the ages of 1835 years. General exclusion criteria for all subjects were as follows: the presence of
disease

conditions

including

diabetes,

cardiovascular

disease,

cancer,

human

immunodeficiency virus, asthma, resting blood pressure >160/100 mm Hg,
hospitalization within the last 6 months, plans to be away for more than 2 weeks in the
next 9 months, significant weight loss in the past year (> 20 kg) or current use of weight
loss medications, being pregnant or planning to become pregnant within the next 6
months.
2.4 Medical and Health History Screening
Subjects in the ETC and ETK first received permission to participate from a State
licensed M.D. or D.O. (Appendix B). Medical clearance was not required for the ACC
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and ACK because they were instructed to follow their normal workout routine without
our supervision.

All study participants completed a medical history form, Physical

Activity Readiness Questionnaire (PAR-Q) and International Physical Activity
Questionnaire (IPAQ) (Appendix B). The above screening and questionnaire were
designed specifically with the participant’s health in mind by: 1) preventing those with
pre-existing conditions from participating in a running program/study and 2) allowing the
researchers to become aware of any potential health issues. Subjects were also informed
of the ingredients found in the product to eliminate any risk of health issues due to
allergens and other food sensitivities. A signed waiver, indicating that food ingredients
and information concerning possible allergens were disclosed, was required from all
participants prior to inclusion in the study (Appendix B).
2.5 Pre-Intervention Data Collection: Baseline Resting Measurements
Baseline

measurements

(body

composition,

blood/saliva

collection,

questionnaires) were taken at the Nutrition and Human Assessment Laboratory, 252
Knapp Hall, Louisiana State University, Baton Rouge, LA. Subjects were instructed to
refrain from exercising on the day of testing and to wear lightweight, comfortable
clothing (including a sports bra and shorts underneath) that did not contain any metal.
Upon arrival, the subjects were given the Participant Consent Form (Appendix C) and
given time to review the document. Then, the experimental protocol was explained, and
any questions posed by the subjects were answered.
2.5.1 Body Circumference/Body Composition
Skinfold measurements were taken in triplicate from three sites by a kinesiology
graduate student, Laura Forney. For men the three sites measured were chest, abdomen
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and thigh; for women the three sites measured were triceps, suprailiac and thigh.
Measurements were taken by pinching the skin and then measuring with a spring-loaded
Lange skinfold caliper (Cambridge Scientific Industries, Inc., Cambridge, MA) allowing
the caliper to pinch the skin. Subjects were made aware of slight discomfort and possibly
bruising on rare occasions experienced from the pinching and measuring of skinfolds.
Hip and waist circumference was measured using a Gullick anthropometric tension tape
(Patterson Medical, Cedarburg, WI). Subjects were then weighed barefoot on a digital
platform scale and height was measured using a stadiometer.
2.5.2 Saliva Collection
Saliva was collected from all study participants. The subjects were asked to fast
for at least four hours before the scheduled donation time. Briefly, subjects were
instructed to passively drool by tilting their head forward, allowing saliva to pool on the
floor of the mouth, and, without force, the pass the saliva into a sterile tube for 10
minutes or until four 1 ml polypropylene vials were filled. All samples were labeled with
subject codes and elapsed time to completion was recorded for each participant. The
filled sample vials were kept in wet ice during the collection period and then frozen in a
laboratory chest freezer at -80°C until analysis.
2.5.3 Blood Collection
Venus whole blood (10 mL per sample) and plasma/serum samples (10 mL per
sample) (20 mL total) were collected before (PRE) and following (POST) the
intervention period from consenting study participants; the blood sample collection was
not a mandatory measurement. Consenting participants were compensated $25 for each
blood sample collection.

Subjects arrived to the Nutrition and Human Assessment
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Laboratory (252 Knapp Hall, Louisiana State University, Baton Rouge, LA) between
6:00 and 9:00 AM following an overnight fast and having refrained from exercise for the
previous 72 hours. The subjects were seated quietly for 15 minutes before the blood
samples were collected by a Registered Nurse, Nicole Petty. Aliquots designated for
plasma

were

collected

in

a

Vacutainor™

blood

collection

tube

containing

ethylenediaminetetraacetic acid (EDTA) (BD, Franklin Lakes, NJ), a strong
anticoagulant, and the tubes were centrifuged (within 5 minutes following collection) for
15 minutes at 1000 x g and 4°C in order to separate the plasma from the cells. The
plasma was transferred to microcentrifuge tubes, labeled with subject codes and stored in
a laboratory chest freezer at -80°C until analysis. Aliquots to be used for analysis of
serum components was collected in a Vacutainor™ blood collection tube containing a clot
activator.

The blood was allowed to clot by sitting at room temperature for

approximately 60 minutes before it was centrifuged for 15 minutes at 1000 x g and 4°C.
2.5.4 Timed 1.5 Mile Run/Walk
The timed 1.5-mile walk/run served as the baseline exercise measurement for all
subject groups. Subjects were instructed to cover 1.5 miles in the fastest possible time
(walking was allowed, but the objective was to finish in the shortest amount of time).
The elapsed time was called out and recorded (in minutes) as the subjects crossed the
finish line.
2.6 Exercise Training
The marathon training program consisted of two supervised training sessions
(running, swimming, strength training/drills) and one unsupervised training session each
week during the 15-week training period (Appendix A). The unsupervised training
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sessions were self-reported; however, the athletes were encouraged to participate in a
student-led running group.
2.7 Kefir Supplementation
Kefir and control beverages were administered in isocaloric amounts to the ETK
and ETC groups within 30 minutes after completion of a Tuesday and Thursday run at
approximately 4:00 PM (Appendix A). Subjects in the ACK and ACC groups consumed
the beverages during Tuesday/Thursday class periods scheduled from 1:40 to 3:00 PM.
Beverage consumption was supervised, and all empty beverage bottles were returned to
ensure the beverages were being consumed in full and also to identify any absent study
participants (Figure 17). Participants who were absent during a scheduled class period or
training session were given 24 hours to complete the training session (ETC and ETK) and
to consume the beverage.
2.8 Sickness and Injury Questionnaires
Throughout the 15-week training period, subjects in both training and active
control groups completed weekly reports that included a sickness questionnaire
(instances, duration and severity of illness) and a training and injury recall log (type,
severity, duration) (appendix E). The questionnaires were distributed to the participants
at the beginning of each Tuesday class period and returned to the investigators the
following Tuesday. Detailed instruction regarding proper completion of the
questionnaires was provided at the beginning of the study.
2.9 Athlete Burnout Questionnaire
To assess the emotional response to training by athletes throughout the 15 week
training program, the Athlete Burnout Questionnaire (ABQ) (Raedeke and Smith, 2001)
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was used (Appendix E). The ABQ contains 15 items that assess three subscales of sport
burnout: a reduced sense of accomplishment, emotional and physical exhaustion, and
sport devaluation. Participants responded using an ordinal scale ranging from 1 to 5, with
1 denoting “almost never” and 5 denoting “almost always.” The 1st and 14th items were
reversed scored. The questionnaires were distributed to the participants at the beginning
of each Tuesday class period and returned to the investigators the following Tuesday.
Detailed instruction regarding proper completion of the ABQ was provided at the
beginning of the study.
2.10 Sensory Surveys
Subjects were also asked to complete brief sensory questionnaires relating to the
beverage and its sensory attributes (appendix F). Before beginning the intervention the
study participants were given a survey containing questions relating to prior knowledge
of sport nutrition and types of foods and beverages, if any, being consumed following
exercise.

The preliminary sport nutrition survey also contained questions regarding

consumption of kefir and other fermented dairy products. The participants completed a
product evaluation survey on the first day that they received their beverage as well as two
additional times during weeks 4 and 10 of the intervention period. For this survey the
participants were asked to evaluate the product and mark their response on a 9-point
hedonic scale with 1=Dislike Extremely and 9=Like Extremely.

Sensory attributes

included on the product evaluation form included aspects of appearance, aroma, taste and
overall liking. The third sensory evaluation was in the form of an exit survey; questions
in this survey related directly to the participants willingness to buy this product,
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perceived effects of this product on exercise recovery and overall experience of
consuming the product.
2.11 Post-Intervention Data Collection
One week prior to the marathon event, participants in the training and the active
control groups underwent post-training measures. Procedures for post-training
measurements were identical to the protocol followed for the baseline resting and
exercise measures as outlined in the Pre-intervention measurements (see Chapter 2.5).
2.12 Sample Analysis: Enzyme-Linked Immuno-Sorbent Assay (ELISA)
Wells of a microtiter plate were coated with polyclonal antibodies that were
directed against the samples and standards. Samples and standards containing the target
compound were added to the microtiter plate and the target compound in the samples was
bound, in excess, to the coated polyclonal antibodies (the capture antibody) in the first
incubation step; washing removed any unbound substances. Prior to a second incubation,
an antibody specific to the target compound was added, binding to the target compound
that was immobilized in the first incubation; another washing removed all unbound
substances. The solid phase was then incubated with an enzyme and a substrate. The
enzyme bonded to the target compound/antibody complex and acted upon the added
substrate to produce a color of varying intensity that was, depending on the particular
assay, either directly or inversely proportional to the amount of target compound present
in the sample. Serum CRP was measured using an ELISA (Alpco Diagnostics, Salem,
NH). TNF-α was measured using a TNF-α enzyme linked immune-sorbant assay
(ELISA) (Alpco, Salem, NH). Salivary IgA was measured using a Salivary Secretory
IgA Enzyme Immunoassay Kit (Salimetrics, State College, PA).
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2.12.1 CRP ELISA
A wash buffer was made by diluting 50 ml of the wash buffer concentrate with
450 ml of deionized water, yielding a 1:10 solution. Crystals occurring in the wash
buffer concentrate, due to high concentrations in stock solutions, were dissolved at 37°C
in a warm water bath prior to dilution. The wash buffer remaining following completion
of the assay was kept in refrigerated storage for use in subsequent CRP assays. The
conjugate was diluted to a 1:100 solution by adding 100 microliters (µl) of the conjugate
concentrate into 9900 µl of the previously diluted wash buffer. Plasma samples were
diluted to 1:100 by adding 10 µl plasma to 990 µl of the sample buffer. A dilution factor
of 100 was used to calculate the CRP concentration read off of the calibration curve
generated for each assay.
Prior to use in the assay all reagents and samples were allowed to come to room
temperature (18-26°C) and were mixed thoroughly. To begin, the microtiter strips were
washed 5 times by dispensing 250 µl of diluted wash buffer into each well. After the
final washing step the residual wash buffer was removed by tapping/blotting the plate on
clean, absorbent paper towels. To duplicate wells, 100 µl of each sample standards and
controls were added. The plate was covered tightly and incubated for 1 hour at room
temperature on a horizontal mixer.
After the incubation period the contents of each well were discarded by quickly
inverting the microtiter plate, and the wells were washed 5 times by dispensing 250 µl
wash buffer into each well. The residual wash buffer was removed by tapping the plate
on absorbent paper towels. Following washing 100 µl conjugate was added to each well.
The plate was covered tightly and allowed to incubate for another hour at room
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temperature on a horizontal plate mixer. After the incubation period the contents of each
well were discarded, and the wells were washed 5 times by dispensing 250 µl bash buffer
into each well. The residual wash buffer was removed by tapping the plate on absorbent
paper towels. Addition of 100 µl of substrate into each well was followed by a 10-20
minute incubation at room temperature in the dark. Because the intensity of the color
change was temperature sensitive, the color change was observed and the reaction was
stopped once good differentiation is achieved. The reaction was stopped by addition of
50 µl of stop solution, which was mixed thoroughly by gently tapping the side of the
plate.
The absorption was determined immediately following completion of the assay
with a microplate reader set to a detection wavelength of 450 nanometers (nm). A 4parameter-algorithm was used to calculate the results. A linear ordinate was used for
optical density and a logarithmic abscissa was used for concentration with a zero
calibrator specified for values less than 1 (e.g. 0.0001). The values obtained from the
calibration curve were multiplied by 100 in order to calculate the CRP concentration in
the plasma samples.
2.12.2 TNF-α ELISA
The provided Human TNF-α (Hu TNF-α) standard was reconstituted to 2000
picograms per milliliter (pg/mL) with standard diluent buffer. The solution was swirled
gently to mix and allowed to sit for 10 minutes to ensure complete reconstitution. After
10 minutes 0.300 mL of the reconstituted standard to a tube containing 0.300 mL of the
standard diluent buffer and was labeled 1000 pg/mL Hu TNF-α Mix. Then 0.300 mL of
the standard diluent buffer was added to each of six 1.5 mL sample tubes labeled 500,
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250, 125, 62.5, 31.2 and 15.6 pg/mL Hu TNF-α. These were the standards used to
produce the standard curve.
The standards were made from the first dilution: 0.300 mL of the contents were
transferred from the provided standard to a tube containing 0.300 mL of the standard
diluent buffer and the respective serial dilutions were made. A tube containing 0.300 mL
of the standard diluent buffer only was used as the 0 pg/mL standard for the purposes of
constructing the standard curve. The streptavidin horse-radish peroxidase (streptavidinHRP) was prepared by adding 120 µL of the concentrate with 12 mL of streptavidin-HRP
diluent. The diluted solution was labeled streptavidin-HRP working solution. The wash
buffer concentrate (25X) was allowed to reach room temperature and was mixed well to
ensure that any precipitated salts were re-dissolved.

One part of the wash buffer

concentrate (25X) was mixed with 24 parts of deionized water. Working wash buffer was
prepared by diluting by adding 50 mL of wash buffer concentrate with 1,200 mL
deionized water.
All reagents were allowed to reach room temperature and the liquids gently mixed
before use. First, 100 µL of the standard diluent was added to zero wells and 100 µL of
the standards, samples and controls were added to the microtiter wells. Then, 50 mL of
incubation buffer was added to the wells containing the standards and the serum samples.
The plate was covered and incubated at room temperature for 2 hours. Following
incubation, the solution was thoroughly decanted from the wells and discarded. The wells
were then washed 4 times. The working wash buffer solution was put into a squirt bottle
and the plate was flooded with wash buffer, completely filling all the wells. The plate
was inverted and tapped dry on clean paper towels after each wash. Each well, except the
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chromogen blank, received 100 µL of biotinylated anti-TNF-α (biotin conjugate) solution
and the plate was gently tapped on its side to mix. The plate was covered and incubated at
room temperature for 1 hour. Following incubation, the solution was again decanted and
discarded and the plate was washed 4 times. Each well, except the chromogen blank,
received 100 µL of streptavidin-HRP working solution. The plate was covered for
incubation at room temperature for 30 minutes. Following incubation, the plate was
decanted and washed 4 times, and 100 µL of the stabilized chromogen was added. Upon
the addition of the stabilized chromogen the liquid in the wells began to turn blue. The
plate was then incubated in the dark for 30 minutes. After the final incubation 100 µL of
the stop solution was added to each well and the plate was tapped gently to mix. The
stop solution caused the solution in the wells to change from blue to yellow.
The absorbance of each well was read at 450 nm. The plate reader was calibrated
against a chromogen blank composed of 100 µL each of stabilized chromogen and stop
solution. The plates were read immediately after adding the stop solution.
2.12.3 SIgA ELISA
All reagents were allowed to come to room temperature (approximately 25°C)
and were mixed thoroughly before use by inverting each bottle several times. The
microtiter plate was also allowed to come to room temperature at this time. Precipitated
matter in the concentrated wash buffer was re-dissolved by heating the concentrate bottle
to 40°C for approximately 10 minutes; the concentrate was allowed to return to room
temperature before use in the assay. The wash buffer was prepared by adding 100 ml of
the 10X concentrate into 900 ml of deionized water to create a 1:10 dilution.
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SIgA diluent was prepared by diluting the 50 ml of the sIgA diluent concentrate
into 200 ml of deionized water to make a 1:5 dilution. The lyophilized stop solution was
reconstituted with 10 ml of deionized water and was allowed to sit undisturbed for 10
minutes before mixing well.
To prepare the sIgA standards 6 microcentrifuge tubes were labeled 1 to 6; 15 µl
of the provided 600 µg/ml standard (tube 1) was added to tube 2 and 30 µl of the sIgA
diluent was added into tubes 2 through 6. The standards were serially diluted as follows:
15 µl of the 600 µg/ml standard was added to tube 2 and the tube was briefly vortexed, 15
µl of the solution from tube 2 was pipetted into tube 3. This dilution was continued for
tubes 4, 5 and 6 yielding final concentrations of 600 µg/ml, 200 µg/ml, 66.7 µg/ml, 22.1
µg/ml, 7.4 µg/ml, and 2.5 µg/ml.
The samples were vortexed followed by centrifuging for 10 minutes at 3000
revolutions per minute (rpm) for 15 minutes to remove any mucins that could interfere
with antibody binding in the sample wells. From the clear portion 25 µl of each sample
was pipetted from the centrifuged samples into small microcentrifuge tubes labeled with
the identity of each saliva sample and containing 100 µl of the prepared sIgA diluent to
create a 1:5 dilution. Each tube was lightly vortexed to mix. Finally, 10 µl of the
standards, controls, and 1:5 diluted unknowns were added to separate 12 x 75 mm capped
tubes containing 4 ml of the sIgA diluent, and 10 µl of the sIgA diluent was added to a
zero tube. All tubes were vortexed to mix.
An initial incubation with the conjugate was performed in the tubes containing the
standards, controls and unknown samples. They were inverted several times to mix and
were incubated at room temperature for 90 minutes. Before transfer to the assay plate the
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tubes were inverted again, and 50 µl from each standard, control and sample tube was
added to the respective well on the microtiter plate. An amount of 50 µl of the sIgA
diluent was added to each well. The plate was covered and incubated at room temperature
for 90 minutes with continuous shaking at 400 rpm. Following incubation the plate was
washed and decanted 6 times by adding 300 µl of the wash buffer into each well. The
plate was blotted on clean paper towels. To each well 50 µl of the provided 3,3’,5,5’tetramethylbenzidine (TMB) solution was added with a multichannel pipette. The plate
was then mixed on a horizontal plate mixer for 5 minutes at 500 rpm and incubated for an
additional 40 minutes at room temperature in the dark. With a multichannel pipette, 50 µl
of stop solution was added to each well. The plate was then mixed on the horizontal
mixer for approximately 3 minutes at 500 rpm, until all the wells turned from green to
yellow.
Immediately following completion of the assay the plate was placed in a
microplate reader at 450 nm. The average optical densities (OD) for each set of duplicate
sample wells, the percent of SIgA bound (B/Bo) for each standard, control and sample
was determined by dividing the average OD (B) by the average OD for the zero (Bo).
The concentrations of the controls and unknowns were determined by interpolation by
logistics using a 4-parameter non-linear regression curve fit (Gen5 Data Analysis
Software, Winooski, VT).

The concentrations of unknown saliva samples were

multiplied by 5 to obtain the final SIgA concentrations in µg/ml. Samples that had values
greater than 600 µg/ml were tested again, in subsequent assays, by preparing the samples
with a higher dilution ratio and re-running for more accurate results.
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2.13 Statistical Analysis
All statistical analysis was carried out in JMP Pro 11 (SAS Software, Cary, NC).
A MANOVA was used to identify significant interactions (p<0.05). Group means and
standard deviations were calculated for all descriptive and outcome variables. Student’s
t-tests were performed post hoc for any significant differences detected at the α = 0.05
level. All CRP, TNF-α and sIgA samples were tested in duplicate. Concentrations of
CRP were log transformed to adjust for normality for statistical analysis. Mean burnout
scores and standard deviations were computed for each burnout subscale to determine the
student-athletes’ burnout levels. A series of one-way between-subject ANOVAs and
independent t-tests were computed to identify and further examine any significant
differences in burnout levels. Data from sensory testing was also analyzed using JMP
Pro 11 (SAS Software, Cary, NC). For the sensory testing, ANOVA was done to analyze
the questions with the 9-point hedonic scale (Peryam and Pilgrim, 1957). A frequency
count was used to analyze the subject responses to Yes/No questions presented in the
preliminary and exit surveys.
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CHAPTER 3. RESULTS AND DISCUSSION
3.1 Endurance Training
The effect of exercise training and kefir supplementation on 1.5-mile times is
shown in Figure 9. There was a significant time x training group interaction (p = 0.0124)
(Figure 21) with the ET groups (ETK and ETC) experiencing an average of 4.11%
improvement in 1.5-mile time (Table 10).
*	
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Figure 9. 1.5-mile time for subject groups before and after the 15-week intervention
period. *Means for each bar differ significantly (P < 0.05). 1.5-mile times are reported as
mean ± SD. Pre exercise training and post exercise training values were collected at the
beginning and the conclusion of a 15-week marathon training program. ETC=Exercise
Training + Control Beverage; ETK=Exercise Training + Kefir Beverage; ACC=Active
Control + Control Beverage; ACK= Active Control + Kefir Beverage.

There was a significant (p<0.05) improvement in the 1.5-mile times with the ETK
group having a Pre time of 12.24 minutes and Post time of 11.74 minutes, resulting in a
30 second improvement for the group. The ETC group had an average 1.5-mile time of
11.98 minutes at the beginning of the 15-week protocol (Pre) and 11.79 at the end of the
intervention period (Post). While the ET groups had no significant change (ETC) or
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significantly (p>0.05) improved 1.5-mile times (ETK), both the ACC and the ACK
groups had significantly (p<0.05) slower times Pre-intervention as compared to Postintervention. The ACC group had an average Pre time of 13.14 minutes and a post time
of 14.02 minutes, which was a significant (p<0.05) increase in 1.5-mile time by 46
seconds. The ACK group had an average Pre time of 14.35 minutes and an average post
time of 15.39 minutes resulting in a significant (p<0.05) increase in 1.5-mile time by 62
seconds.
Table 10. Average percent change in 1.5-mile walk/run times for endurance training
athletes and an active control consuming a kefir recovery beverage and a control
beverage.
ETC

Percent change in
1.5-mile time
-1.6909a

ETK

-4.3174a*

ACC

9.1068b

ACK

6.9827b

Treatment Group

ab

Group means not connected by a common letter are significantly different (p < 0.05).
Significant improvement (p<0.05) in mean1.5-mile time. ETC=Exercise Training +
Control Beverage; ETK=Exercise Training + Kefir Beverage; ACC=Active Control +
Control Beverage; ACK= Active Control + Kefir Beverage.
*

The improvement in mean 1.5-mile time in the ETK group demonstrated the
effectiveness of the training program in achieving the desired results. The endurance
capacity i.e. aerobic capacity is most the often and most accurately measured by the
maximum oxygen uptake (VO2max) during a graded exercise (treadmill) test. However,
testing the VO2max of individual subjects can be both costly and time consuming. The
1.5-mile walk/run test has been shown as a valid measure to estimate VO2 max and is
commonly used in a college setting when it is necessary to test a large number of people
at one time (Larsen, et. al., 2002).
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While accepted as a suitable VO2max predictor in lieu of a graded exercise test
(Jeukendrup, et. al. 2010), there are several factors that may limit the accuracy of the 1.5mile walk/run test such as the undetermined accuracy and validity of the 1.5-mile
protocol between male and female populations (Kline, et. al., 1987). Also, although
participants were instructed to “complete the course in as fast a time as possible”
untrained individuals may not have been able to maintain a proper pace resulting in a 1.5mile time that does not represent the actual endurance capacity.
3.2 Body Density and Percent Body Fat
The skinfold measurement equations estimated body density, which was then
used to estimate percent fat. The two generalized equations used to calculate body
density were from Jackson and Pollock (1978) for men and Jackson, Pollock, and Ward
(1980) for women (Table 11).
Table 11. Equations used for the calculation of body density and percent body fat based
on skinfold data collected during resting baseline measurements.
Body Density

Skinfold Measurements

Females

1.0994921 - 0.0009929*Σ + 0.0000023*Σ2 - 0.0001392*age

triceps, suprailiac, thigh

Males

1.1093800 - 0.0008267*Σ + 0.0000016*Σ2 - 0.0002574*age

chest, abdominal, thigh

Percent Body Fat

✜

[(4.570 / Body Density) - 4.142] * 100

Σ = sum of skinfold
measurements
✜ percent body fat equation
for males and females

Body density was calculated by the Body density of the participants before and
after the 15-week training period is reported in Figure 10. No significant differences
(p>0.05) in body density were found between or within groups.
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Figure 10. Body density of study participants before and after the 15-week intervention
period. There were no significant (p>0.05) differences in density body found between
treatment groups or pre-intervention and post-intervention. Body density is reported as
mean ± SD. Pre exercise training and post exercise training values were collected at the
beginning and the conclusion of a 15-week marathon training program. ETC=Exercise
Training + Control Beverage; ETK=Exercise Training + Kefir Beverage; ACC=Active
Control + Control Beverage; ACK= Active Control + Kefir Beverage.

There were two calculation steps for determining percent fat: determining body
density and then using body density to estimate percent fat. The equation used for
estimating percent fat from body density was the Brozek (2006) formula (see Table 11).
Percent body fat of the participants before and after the 15-week training period is
reported in Figure 11. No significant differences (p>0.05) were found between or within
groups in regards to variations in body fat percentage. These results, indicating that the
participants in this project had no significant fluctuations in weight during the course of
the 15-week protocol, suggest that the kefir beverage and the control beverage did not
differ in their effect on the body composition of participants over the course of the
intervention. The no change in mean body composition of participants in the ETC and
ETK suggest that they were maintaining a diet sufficient in calories to maintain a
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consistent body composition during training, with the supplementation with a dairy based
recovery beverage possibly contributing to this consistency.
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Figure 11. Percent body fat of study participants before and after the 15-week
intervention period. There were no significant (p>0.05) differences in percent body fat
found between treatment groups or pre-intervention and post-intervention. Body fat
percent is reported as mean ± SD. Pre exercise training and post exercise training values
were collected at the beginning and the conclusion of a 15-week marathon training
program. ETC=Exercise Training + Control Beverage; ETK=Exercise Training + Kefir
Beverage; ACC=Active Control + Control Beverage; ACK= Active Control + Kefir
Beverage.

The equations used to determine body density have withstood the test of
numerous cross-validation studies, with standard errors ranging from 3.6% to 3.8%, and
are routinely used in body density assessment by sport and health professionals
(Jeukendrup, et. al., 2010).
However, a limitation to this formula is that it assumes the density of fat-free
mass to remain constant across the population when it in fact varies. The actual percent
body fat tends to be somewhat higher than the measured percent fat in the lean, muscular
individual and the opposite effect in obese individuals (Brožek, et. al., 2006). Table 12
lists current accepted ranges for body fat percentages and their descriptive categories.
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Table 12. Descriptive categories for ranges of body fat percentage ranges in women and
men issued by The American Council of Exercise.
Description
Women
Men
Essential fat 10-13%
2-5%
Athletes
14-20%
6-13%
Fitness
21-24%
14-17%
Average
25-31%
18-24%
Obese
>32%
>25%
(adapted from: American Council on Exercise, 2009)
There were 12 participants out of 67, with the majority in the ETC and ETK
groups, with very small percentages of body fat (>3-5%); this may, in part, be due to the
fact that most of the participants in the ETC and ETK groups, as well as some
participants in the ACC and ACK groups, were trained endurance runners or involved in
athletics requiring low body fat i.e. gymnastics, cheerleading, cycling.
3.3 C-Reactive Protein
There were no significant interactions (p>0.05) with respect to all other outcome
variables of biological inflammatory and immune markers with the exception of serum
CRP. The ETC group had a significant increase (p<0.05) in CRP levels following
training as seen in Figure 12. There was no significant increase (p>0.05) in the level of
CRP in the ETK, ACC or ACK groups. A possible trend was observed for a kefir CRP
interaction with the ETK and ACK groups experiencing percent increases in CRP
following training of 21.18% and 5.45% as compared to the ETC and ACC (64.71%,
22.36%).
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Figure 12. Effect of endurance training and kefir supplementation on serum C-reactive
protein (mg/L). *Means for each bar differ significantly (P < 0.05). Data corresponds to
the average ± SD of the results of subjects from 4 separate groups. Pre exercise training
and post exercise training values were collected at the beginning and the conclusion of a
15-week marathon training program. ETC=Exercise Training + Control Beverage;
ETK=Exercise Training + Kefir Beverage; ACC=Active Control + Control Beverage;
ACK= Active Control + Kefir Beverage.

The training program resulted in significantly increased (p<0.05) CRP levels in
the ETC. This increase could possibly be attributed to increased inflammation in the
body due to the strenuous training regime. The CRP level in the ETK group following
training was not significantly different than the initial CRP level. The CRP level in the
ETK group following training may indicate that supplementation with the kefir beverage
could have a beneficial effect in regards to reducing the amount of exercise induced
inflammation as measured by circulating CRP. The effect of exercise on CRP was
examined by Stewart, et. al. in a 2007 study using active and previously inactive training
groups. Their results showed that both groups had a significant decline in serum CRP
from pre- to post-training, with the most marked decrease in serum CRP (58%) occurring
in the previously inactive group. The participants in the ETC and ETK groups had been
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exercising prior to this study in preparation for the endurance training which may have
influenced a trend towards lower initial resting CRP levels.
Individuals with a level of serum CRP of <l mg/L a considered to be at low risk
for cardiovascular disease (CVD), individuals with values from 1–3 mg/L at moderate
risk and greater than 3 mg/L are at high risk for CVD (see Table. 4). Based on these risk
factors and the CRP means Pre and Post, we see a definite correlation between trained
and untrained individuals in respect to overall risk for CVD. Average serum CRP
concentrations in ACC both Pre and Post intervention (1.24 mg/L and 1.30 mg/L) were in
the moderate-risk category. Average value for the ACC group Pre intervention (0.944
mg/L) was on the very high end of the low risk category, and the Post intervention
average CRP level (1.15 mg/L) rose to the moderate risk category. The ETC and ETK
groups both had average CRP levels (ETC: 0.255 mg/L and 0.725 mg/L; ETK: 0.746
mg/L and 0.588 mg/L) that started at and remained in the low risk for CVD category Pre
and Post intervention.
These possible effects of kefir on attenuating CRP in s individuals participating in
strenuous exercise programs may indicate a suppression of pro-inflammatory pathways
caused by increased stress on the body.

Supplementation with kefir could also be

stimulating an anti-inflammatory response and anti-oxidative pathways in participants
following training which might also explain the lack of CRP elevation post-intervention
in the ETK group.
3.4 Tumor Necrosis Factor-α
There were no significant (p<0.05) interactions among groups with respect to
levels of TNF-α. The levels of TNF-α showed no significant (p<0.05) change between
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samples collected Pre-intervention and Post-intervention within the treatment groups
(Figure 13).
4
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Figure 13. Effect of endurance training and kefir supplementation on TNF-α (pg/ml).
There were no significant (p>0.05) differences in TNF-α found between treatment groups
or pre-intervention and post-intervention. Blood samples were collected before and after
completion of the training/intervention period. Data correspond to the average ± SD of
the results of subjects from 4 separate groups. Pre exercise training and post exercise
training values were collected at the beginning and the conclusion of a 15-week marathon
training program. ETC=Exercise Training + Control Beverage; ETK=Exercise
Training + Kefir Beverage; ACC=Active Control + Control Beverage; ACK= Active
Control + Kefir Beverage.

Previous studies examining the levels of soluble circulating TNF-a in plasma have
yielded varying results. An average TNF-α of 5.7 for 24 women ages 19 to 39 was found
in one study (Bullo, et. al., 2002) while another study including 307 women ages 19-49
was reported a TNF-a 10.30 with values ranging from 5.45-19.86 (Himmerick, et. al.,
2006). The normal value for college age active women and men is most likely reflected
an average TNF-α level, as the levels of circulating TNF-α typically trend upward during
aging (Bruunsgaard, et. al., 2002).
While some cytokines, such as interleukin-6, are strongly associated with CRP
and other inflammatory biomarkers, the association between TNF-α and CRP is rather
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weak (Tsukui, et. al., 2000). This suggests that circulating levels of maybe influenced by
a number of different factors and that circulating TNF-α levels may not reflect biologic
activity at the tissue level. Several studies have demonstrated significant increases in
circulating cytokines, including TNF-α, when samples were collected immediately
following strenuous activity (King, et. al., 2000; Bullo, et. al., 2002; Himmerich, et, al.,
2003). The serum samples in this study were collected from rested participants having
abstained from activity for 24 hour prior to collection, which may have been a factor in
the failure of this study to demonstrate significant training effects of TNF-α. Because the
groups had no significant differences (p>0.05) in the level of TNF-α pre-intervention and
post-intervention or between groups, no conclusions could be made regarding the effects
of probiotics on attenuating the elevation expected following a high intensity training
session. However, it has been shown that deleterious effects of TNF-alpha and IFNgamma on epithelial function can be prevented by probiotic treatment and the effect of
bacteria on intestinal epithelial function may justify their use in inflammatory disorders
(Resta-Lenert and Barrett, 2006).
3.5 Frequency of Sickness and Injury
The total reported sicknesses are reported in Figure 14. ETK (79 sicknesses) and
ETC (64 sicknesses) had a much higher number of reported sicknesses than ACC (20
sicknesses) and ACK (19 sicknesses) even though the sample sizes for ETC (n=10) and
ETK (n=13) were much lower than ACC (n=21) and ACK (n=21). The frequency of
sickness was found to be significantly higher (p<0.05) in ETK and ETC as compared to
ACK and ACC (Figure 14). There were no significant differences found in frequency of
sickness between ETK and ETC or between ACK and ACC.
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Figure 14. Total reported sickness during the 15-week intervention period.
ETC=Exercise Training + Control Beverage; ETK=Exercise Training + Kefir Beverage;
ACC=Active Control + Control Beverage; ACK= Active Control + Kefir Beverage;
ET=ETC+ETK; AC=ACC+ACK

The average reported sicknesses (Table 13) of the ETC (6.4±4.08) and ETK
(5.64±3.93) groups were significantly higher than the ACC (2.34±2.79) and ACK
(1.31±1.16) groups due to well documented perturbations in immune functioning
following intensive training.
Table 13. Average incidences of sickness for endurance training athletes and an active
control consuming a kefir recovery beverage and a control beverage during a 15-week
marathon training program.

ab

Treatment group
ETC
ETK
ACC
ACK

Mean
6.40a
5.64a
2.34b
1.31b

SD
4.08
3.93
2.79
1.167

Pairs not connected by a common letter are significantly different (p < 0.05).
ETC=Exercise Training + Control Beverage; ETK=Exercise Training + Kefir
Beverage; ACC=Active Control + Control Beverage; ACK= Active Control +
Kefir Beverage.
Many of the exercise-induced changes in immunity are similar to changes
associated with other forms of stress, such as sleep deprivation, aging and psychological
stress. Pederson, et. al. (2000) concluded that because the underlying mechanisms
involved in exercise and stress induced inflammation are multifactorial and include both
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neuroendocrinological and metabolic factors, nutritional supplementation may protect
against the increased risk of infection in the recovery period after strenuous exercise. If
probiotics can improve immunity in athletes, then they may also be suitable for
improving immunity in other individuals exposed to regular stress, such as the military
and shift workers (Vinderola, 2004). Results from this study indicate that while the
instances of illness do indeed increase with an intensive training load, an a trend
indicating possible attenuation of the severity or frequency of sickness in athletes could
be, in part, due to the benefits incurred by kefir consumption.
The total reported injuries are reported in Figure 15. ETK (70 injuries) and ETC
(98 injuries) had a much higher number of injuries than ACC (20 injuries) and ACK (19
injuries) even though the sample sizes for ETC (n=10) and ETK (n=13) were much lower
than ACC (n=21) and ACK (n=21).
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Figure 15. Total reported injury during the 15-week intervention period. ETC=Exercise
Training + Control Beverage; ETK=Exercise Training + Kefir Beverage; ACC=Active
Control + Control Beverage; ACK= Active Control + Kefir Beverage; ET=ETC+ETK;
AC=ACC+ACK
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The average number of reported injuries for ETC and ETK were significantly
(p>0.05) higher than average number of injuries reported by ACC and ACK. There were
no significant differences found in frequencies of sickness and injury pre-intervention as
compared to post-intervention between ETK and ETC or between ACK and ACC.
Table 14. Average number of injuries for endurance training athletes and an active
control consuming a kefir recovery beverage and a control beverage during a 15-week
marathon training program.
Treatment group
ETC
ETK
ACC
ACC

Mean
7.357a
6.500a
1.455b
0.9523b

SD
2.309
3.616
1.657
1.700

a

Pairs not connected by a common letter are significantly different (p < 0.05).
ETC=Exercise Training + Control Beverage; ETK=Exercise Training + Kefir
Beverage; ACC=Active Control + Control Beverage; ACK= Active Control + Kefir
Beverage.
The significantly higher (p<0.05) incidences of injury in the ETC and ETK
groups as compared to the ACC and ACK groups (Table 14) was expected due to the
increases likelihood of sport related injury accompanying long distance running
programs.
3.6 Athlete Burnout
The Athlete Burnout Questionnaire (ABQ) (Raedeke and Smith, 2001) consists of
15 sport specific items with each question being “How often do you feel this way?”
Athletes were asked to rate the extent to which they experienced each item in relation to
their participation motives on a 5-point Likert scale with 1 = almost never to 5 = almost
always (Appendix E). The ABQ had three 5-item subscales assessing 3 key dimensions
of burnout: Reduced sense of accomplishment (e.g., “It seems that no matter what I do, I
don’t perform as well as I should”); Emotional and physical exhaustion (e.g., “I feel so
tired from my training that I have trouble finding energy to do other things”);
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Devaluation of sport participation (e.g., “The effort I spend participating in my sport
would be better spent doing other things”).
There were no significant (p>0.05) interactions found among groups with respect
to athlete burnout and attitudes about exercise and sport (Table 15).
Table 15. Three measures of athlete burnout in athletes and an active control consuming
a kefir recovery beverage and a control beverage during a 15-week endurance training
program.
ETC
ETK
ACC
ACK

Emotional and Physical Exhaustion
1.821
2.076
1.801
1.904

Sense of Accomplishment
1.911
2.150
1.915
1.912

Sport Devaluation
1.642
1.631
1.647
2.043

Three 5-item subscales in the Athlete Burnout Questionnaire assessing 3 key dimensions
of burnout were used. There were no significant (p>0.05) differences in the athlete
burnout measures found between treatment groups. Values are reported as mean value of
participation motives on a 5-point Likert scale with 1 = almost never to 5 = almost
always. ETC=Exercise Training + Control Beverage; ETK=Exercise Training + Kefir
Beverage; ACC=Active Control + Control Beverage; ACK= Active Control + Kefir
Beverage.
The three measures of athlete burnout (Emotional and Physical Exhaustion, Sense
of Accomplishment, Sport Devaluation) showed no significant (p>0.05) differences
between the four treatment groups or between the training participants (ETC and ETK
combined) and the exercise controls (ACC and ACK combined).
“Overtraining” is defined by Buggett (1998) as “a non-deliberate long-term
decrement in performance capacity resulting from a failure to recover adequately from an
accumulation of training and non-training stress”.

It is common for elite athletes,

especially young and inexperienced competitors, to “push themselves too far, overreach,
constantly experience extreme tiredness on a regular basis and never realize their full
potential or achievement capability (Gould and Dieffenbach, 2002). In athletes, burnout
can be a result of excessive training and insufficient recovery following training.
Kellman (2002) describes this type of overreaching as a deliberate part of the training and
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recovery process needed to achieve desired performances, with performance
incompetence being a temporary effect (Lehmann, et. al., 1999). This short-term lowered
performance capacity state can be restored with the help of a brief recovery period
(Meeusen, et. al., 2006).

In contrast to functional overreaching, non-functional

overreaching e.g. overtraining often results in athlete burnout due to a combination of
excessive overload and inadequate recovery and can lead to severe psychological and
physiological symptoms. Because no significant differences were observed in ABQ
scores between ETC and ETK and no burnout was observed, the beverages provided to
the athletes may have aided in recovery and preventing burnout due to overtraining.
3.7 Consumer Survey and Sensory Analysis
In all groups, the vast majority of participants believed that food would aid in
recovery following exercise, with only 4 participants in the AC groups (ACC and ACK)
responding “not sure”.

When asked how long following exercise food is typically

consumed, responses were varied, with most reporting eating within an hour following
exercise, and, when asked what they ate at that time, the two most common responses
were “smoothie” and “shake”, as reported by 23 of the total 67 participants. Other
common responses were “gatorade/powerade” (4 responses), “granola bar” (3 responses)
and “dinner” (3 responses). Four participants in the ET group (n=25) and 5 participants
in the AC group (n=42) reported consumption of dairy products (milk, yogurt, whey
protein) following exercise.
Based on responses to questions regarding preexisting post-exercise recovery
programs with a food component, information regarding current exercise practice and
implementation of a recovery program was assessed. The majority of participants in all
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groups reported that they were currently exercising at moderate intensity at least 2 times
per week. Five participants in the ET groups (n=25) and 7 out of the AC groups (n=42)
were following an exercise recovery program. For the participants using food to aid in
exercise recovery, common responses were “smoothie” and “protein shake” (23
responses).
Prior to participation in this study, only 6 participants had heard of kefir (N=67),
and 2 individuals had previously consumed kefir. Finally, the participants were asked
about current yogurt and other fermented milk consumption with the response choices
being: Never, Once a week, Two times a week, and More than two times per week (Table
16).
Table 16. Reported consumption of yogurt and other fermented dairy products by college
students (age 18-30 yrs) participating in a marathon-training program and an active
control.
Treatment
group
ECT
ETK
ACC
ACK
Total (N=67)

Never
5
5
5
4
19

Once a
week
2
1
9
12
24

Two times
per week
2
2
3
3
10

> Two times
per week
5
7
4
4
20

ETC=Exercise Training + Control Beverage; ETK=Exercise Training + Kefir Beverage;
ACC=Active Control + Control Beverage; ACK= Active Control + Kefir Beverage.
The goals of the participant survey component of this research were to provide
insight into the perceptions of the role of nutrition in exercise and current dietary
practices in college students and student athletes especially as they relate to dairy foods.
From these results, it is clear that the majority of the college students participating in this
study have limited knowledge regarding recovery from exercise and sport nutrition.
Although there were a few students in the ETK and ETC using dairy products (milk or
yogurt) as part of a recovery program involving food, the introduction of a dairy food
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following exercise was a new recovery implement for a large majority of participants.
The reported rates of fermented dairy consumption indicated that 30% of the participants
were consuming more than 2 servings per week. The majority (51%) of the participants
reported yogurt consumption once or twice a week, and the remainder 29% reported no
consumption of fermented dairy products.
Results of the product evaluation survey are reported in Figure 17. No significant
differences (p<0.05) were found between the kefir beverage and the control beverage for
any of the sensory attributes. This indicates that the control beverage was successfully
matched to the kefir beverage in regards to flavor, texture, appearance and overall

Means

acceptability, which was necessary to maintain the subject blinded experimental design.
9
8
7
6
5
4
3
2
1
0

Kefir Beverage
Control Beverage

Figure 16. Sensory analysis of kefir recovery beverage and control.
The overall acceptance and perceived benefits of the recovery beverages provided
was assessed in an exit survey (Table 17). Results indicate a very positive response to
both beverages overall indicating that majority of participants would buy this product
before and after knowing about possible probiotic benefits from consumption.
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Table 17. Product acceptability and consumer intent of purchase for a kefir based postexercise recovery beverage and a control beverage by athletes participating in a 15-week
marathon training program and an active control.
Acceptability Will purchase
Will purchase this Did consuming this
this product
product after
product following
before knowing knowing about
exercise aid in
about probiotics probiotics
recovery?
yes
no
yes
no
yes no maybe yes
no
maybe
Kefir beverage 35
2
22
1
30
6
26 1
11
11
Control
1
22
32
0
26
6
27 0
5
9

3.8 Limitations
Due to problems encountered with the Secretory IgA Enzyme-Linked-ImmunoAssay test kit (Salimetrics, State College, PA), many of the saliva samples needed to be
reanalyzed. However, there was not enough saliva supernatant to complete the sIgA
assay; therefore, no results are available for average sIgA levels for the treatment groups.
The donation of blood samples from the study participants was not compulsory and
several students from each group did not participate in this portion of the research; in
addition, three students who gave blood at the beginning of the experimental period did
not participate in the post intervention period, and although all groups maintained a size
of n=8, this lowered sample size could have influenced the results of the statistical
analysis, especially because of the high degree of deviation between the participants
within each group. Because a relatively small sample size was collected for testing the
number of assays performed per participant sample was limited.

Several samples that

needed to be re-run due to higher than expected CVs of duplicate samples were
unavailable for subsequent assays; the number of samples in the ETC and ETK groups
dropped to 6 and 7, respectively. The sample size limitations prevented valid statistical
analysis of these groups for sIgA. ELISA methods are useful because they provide high
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specificity and good standardizability between and within assays. Unfortunately, cytokine
assay results may vary due to the methods used for cytokines detection and their
sensitivities, interferences due to different drugs used, and the effect of concomitant
pathologies (Szegedi, et. al. 2003).
Compliance with and beverage consumption was not a major issue. However,
although instructed not to discuss beverage, several participants did compare sensory
aspects such as levels of sweetness and color and made attempts to determine which
beverage (kefir or control) they were consuming. One subject was removed from the
study due to 3 missed beverage treatments. Adherence to the training protocol also
proved challenging for several participants in the ETK and ETC groups.
For this project, the inability to control for variables such as consumption of other
fermented foods or probiotics and other dietary components may have had influenced the
action of the probiotics. Excessive caffeine and alcohol use has also been shown to have
deleterious effects on training, as they can prevent proper rehydration due to increased
diuresis (Burke, et. al., 1997). However, the effect of probiotics on alcohol consumption
and gut homeostasis has demonstrated some interesting results. In a 2009 study by
Forsyth, et. al., rats were gavaged with alcohol twice daily for 10 weeks; the alcoholic
rats

were

also

treated

with

once

daily

gavage

of

either

2.5 × 107 live L.

rhamnosus Gorbach–Goldin (LGG) or vehicle (V). They found that reduced alcoholinduced gut leakiness and significantly blunted alcohol-induced oxidative stress and
inflammation in both intestine and the liver. Another similar study found that Short-term
oral supplementation with B. bifidum and L. plantarum 8PA3 was associated with
restoration of the altered bowel flora and the frequency of endotoxemia associated with
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chronic alcohol consumption and demonstrated an improvement in alcohol-induced liver
injury (Kirpich, et. al., 2008).
A wash out period A group of participants instructed not to consume probiotics
containing foods for a certain period of time leading up to the intervention i.e. wash out
period, or a group of subjects not regularly consuming probiotics or diary products would
have better elucidated the probiotic effects of kefir in combination with a training
intervention.

In addition, a water control for baseline measurements and would

especially help to determine if the consumption this product versus no recovery food
would have a significant effect; however, a third treatment group (water only) was not
possible due to low subject numbers.
This research protocol did not control for antibiotic use by the participants during
illness. Although antibiotic use was not reported by the participants, there was most
likely prevalent antibiotic use, especially in the ETC and ETK groups as they had many
more instances of sickness as compared to the control. The dosage, type and time
receiving antibiotics needed to be assessed to determine the existence of any interactive
effects of antibiotic with exercise training and kefir supplementation.
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CHAPTER 4. CONCLUSIONS AND FUTURE WORK
This study demonstrates the potential for a kefir recovery beverage as an
appealing source of nutrients and probiotics for athletes as an exercise recovery beverage
and for non-athletes as a healthful food product. The significant reduction of milk sugars
by lactic acid bacteria and yeasts during fermentation and the breakdown of proteins into
bioactive peptides and free amino acids most likely increased digestibility, as the
beverage was well tolerated by all of the athletes following intense exercise. The milk
based sports recovery drinks in the present market are processed to increase shelf life and
to remove lactose; however, the development of an all natural, minimally processed
beverage formulated with naturally occurring probiotics will provide athletes of all ages
and skill levels with a healthy alternative to other currently available products.
The effects of kefir on CRP levels in athletes and how this translates to the
mediation of inflammation and immunity via changes in gut health by using keifr
following intense activity may aid in understanding the role of probiotics and other
fermented foods as they relate to human health. Results of this study suggest that
supplementation with kefir during intensive exercise training could possibly attenuate
symptoms or reduce instances of some of the negative side-effects of exercise by helping
to regulate the damage caused by inflammation and oxidative stress.
An important next step in understanding the mechanisms involved in the
immunomodulating and anti-inflammatory effects of consuming kefir following activity
will be further characterization of gut microbiota of various exercising populations,
including individuals with diseases such as cancer and diabetes. Using genomic
sequencing to determine if any significant variations exist in the gut microflora between
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subjects consuming kefir post-exercise would further elucidate the effects and possible
uses of kefir in training, recovery and maintenance of optimal health. Another necessity
would be exploration into the relationship between other bioactive components in milk,
particularly those found in fermented milks, such as bacteriocins, organic acids and
exopolysaccharides, and human health.
Improvement and innovation of processing techniques for fermented products,
with an emphasis on new packaging strategies for dairy products containing live, active
cultures will be crucial for the success of this product on a larger scale. The design of a
packaging system for fluid dairy products containing heterofermentative bacteria and
yeasts allowing a controlled release of excess gas while maintaining a level of
carbonation in the product will be required for a recovery beverage of this type to be
successful in the current food market. In, summary, this study provided useful
information regarding acceptability of a kefir based post-exercise recovery beverage by
athletes and demonstrated an attenuation of exercise induced inflammation following
kefir consumption. Continued exploration of the therapeutic properties of kefir as it
relates to achieving and maintaining optimal health during athletic training will be
necessary to adequately assess the potential benefits of including kefir in a post-exercise
recovery plan.
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APPENDIX B – TRAINING DOCUMENTS
1.1 The Physiology of Endurance Training: Course Flyer
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APPEXDIX B – TRAINING DOCUMENTS
1.2 Marathon Training Plan
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APPENDIX C – CONSENT FORMS
2.1 Research Consent Form – Product Information
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APPENDIX C – CONSENT FORMS
2.2 Participant Consent Form – Explanation of Research Protocols
Participant Consent Form
1. Study Title: The Effects of Post Exercise Consumption of a Fermented Milk Beverage
on Performance and Recovery During Intensive Endurance Training
2. Performance Site: Louisiana State University Baton Rouge, LA 70803
3. Investigators: The following investigators are available for questions about this study,
M-F, 8:00 a.m.- 4:30 p.m. Principle Investigator: Charles Boeneke, Ph.D. 225578-4383 Co-investigators: Keely O’Brien. M.S. 225-578-4382 Laura K.
Stewart, Ph.D. 225-578-3549
4. Purpose of the Study: The purpose of this research project is to examine the effects of
post workout supplementation with a milk beverage on subjects participating in a
15-week intensive marathon training program.
5. Subject Inclusion: Participants in the control and training groups must be at least 18
years of age and currently enrolled students or are employees at LSU. Subjects in
the training group must have medical clearance following a complete
comprehensive physical from a state licensed M.D or D.O. The cleared student
must provide documentation of permission by returning a signed “Physician
Approval Form” after the physical and before participating in the study. Students
in the active control group must complete a physical activity readiness
questionnaire (PAR-Q) before participating. You must be healthy and between
the ages of 18-35 years. General exclusion criteria for all subjects are as follows:
the presence of disease conditions including diabetes, cardiovascular disease,
cancer, HIV, asthma, resting blood pressure > 160/100mmHg, hospitalization
within the last 6 months, plans to be away for more than 2 weeks in the next 9
months, significant weight loss in the past year (> 20 kg) or current use of weight
loss medications, being pregnant or planning to become pregnant within the next
6 months. Information regarding product ingredients and possible allergens will
be provided to you; subjects with allergies or sensitivities to product ingredients
will be excluded.
6. Number of subjects=
Milk beverage 1 + marathon training group: n=20 Milk beverage 2 + marathon training
group: n=20
Milk beverage 1 + active control: n=20 Milk beverage 2 + active control: n=20
Total: N=80 7. Study Procedures:
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Product Development and Manufacture: Products will be manufactured in the LSU
Creamery, a licensed dairy processing facility.
Baseline: Before the 13 week training program begins, you will have baseline
measurements taken. This will include basic baseline measurements such as body weight,
height, waist hip ratio, resting metabolic rate and blood sample collection. An assessment
of your physical fitness will be estimated by having you perform a 1.5 mile run/walk test.
This test will require you to complete 1.5 miles at a maximal effort. A physical fitness
questionnaire will be administered and a dietary log will be kept for one week prior to the
start of the program. An ingredient list will be provided to you prior to consumption of
the product to make you aware of any possible allergens and a product liability waiver
will be collected.
13 Week Intervention Program: At the start of the program, you will be provided with a
suggested training program (training group only). If you choose not to follow this training
program, you will not be penalized. Twice weekly you will be given a 12-ounce portion
of a smoothie type beverage. Throughout the 15-week training period, both groups will
fill out a training log. This should take about 20 minutes weekly to complete. Participants
in the active control group will be instructed to continue their own personal training
programs and participants in both groups will continue to complete weekly training and
diet logs, and sickness inventory questionnaires.
Post-Training: One week prior to the marathon event, you will undergo post-training
measures. Procedures for post-training measurements will be identical to the protocol
followed for preliminary measures.
8. Benefits:
While no guarantee of benefits can be made, you will be given training and nutrition
instruction and a body composition analysis at no cost to you. You may also learn more
about your physical capacity for endurance and should significantly improve your aerobic
fitness. Subjects will be provided a comparison of his/her pre-training and post-training
results at the end of the semester. An optional paid blood collection will be given with
$25 being paid following each of a total of two collections.
9. Risks/Discomforts:
Product Consumption: As with any food product, there is a chance that you may have
certain allergies or food sensitivities to ingredients included in the product. All
ingredients will be disclosed to you prior to consumption of the product to alert you of
any potential health concerns regarding food allergens. You will be required to sign a
waiver acknowledging that you have been informed of this risk prior to the consumption
of the product.
Exercise Training & Testing: As with any exercise program, there is a chance that you
will experience muscle soreness, fatigue, or even injuries such as sprains or strains. There
is also a remote risk of a heart attack or stroke and in very rare cases, death. Precautions
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to minimize this risk have been taken by requiring medical clearance to participate as
well as completion of a health history questionnaire. Your cooperation in obtaining
approval from your physician as well as providing honest answers in completing the
health history form will decrease this risk.
Plasma and Whole Venous Blood Collection: There is risk of bruising and soreness at the
site of blood collection, and the remote risk of fainting.
In addition to the risks listed above, you may experience a previously unknown risk
or side effect.
10.

Injury/Illness: In the unlikely event of injury or medical illness resulting from the
above procedures, contact Laura Stewart, Ph.D., 225-578-3549. You will
be referred for treatment, but the expense of medical treatment will be your
responsibility. No compensation is available in case of study-related illness or
injury.

11.

Right to Refuse: You may choose not to participate or to withdraw from the study
at any time without penalty; however there will be a loss of any benefit to which
you might otherwise be entitled, including monetary compensation for blood
sample collection.

12.

Privacy: Your identity will remain confidential unless disclosure is required
by law. In other words, data will be kept confidential unless release is legally
compelled. All data collected will be handled only by the investigators and kept in
a secure location. Results of the study may be published using group means only
and names or identifying information will not be included in the publication.

13.

Financial Information: There is no cost to you, and compensation will be given if
you

participate in the blood collection portion of the study. $25 will be paid following each
sample collection.
14. Signatures: The study has been discussed with me and all my questions have been
answered. I may direct additional questions regarding study specifics to the investigators.
If I have any questions about subjects’ rights or other concerns, I can contact Robert C.
Matthews, Institutional Review Board at (225) 578-8692. I agree to participate in the
study described above and acknowledge the investigator’s obligation to provide me with
a signed copy of this consent form.
___________________ Participant’s Signature Date
___________________ Witness Signature Date
___________________ Investigator Signature Date
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APPENDIX C – CONSENT FORMS
2.3 Physician Approval Form for Participation in Marathon Training
Physician Approval Form
Kinesiology 4526
The Physiology of Endurance Training
*This physical must be completed by a Louisiana State licensed M.D. or D.O. only*
I have completed a full comprehensive physical examination of _____________________ (print
student’s full name) as required for him/her to participate in Kinesiology 4526 (The Physiology of
Endurance Training). I understand that the student will be engaging in an intensive running and
conditioning program which will involve optional participation in a course-designated Marathon
during the Spring 2012 semester. Based on my physical findings, I am making the following
recommendation related to the demands of the course:
____ Patient is cleared to participate without restriction.
____ Patient is cleared to participate with the following restrictions or guidelines.
__________________________________________________________________
_____ Patient is not cleared to participate.
Physician Signature: _________________________________________________
Physician Name (Print):______________________________________________ _
Date: ______________________________________________________________
Address: ___________________________________________________________
Phone: ____________________________________________________________
Fax: ______________________________________________________________
Email: _____________________________________________________________
If there are questions or concerns, please contact:
Laura K. Stewart, Ph.D.
Department of Kinesiology
112 Long Fieldhouse
Louisiana State University
Baton Rouge, LA 70803
Phone: 225.578.3549
Fax: 225.578.3680
stewart6@lsu.edu
*Please return this completed form to Laura Stewart, Ph.D.*
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APPENDIX D - PHYSICAL ACITIVTY ASSESSMENT FORMS
3.1 Physical Activity Readiness Questionnaire (PAR-Q)

PAR-Q & YOU

Physical Activity Readiness
Questionnaire - PAR-Q
(revised 2002)

(A Questionnaire for People Aged 15 to 69)
Regular physical activity is fun and healthy, and increasingly more people are starting to become more active every day. Being more active is very safe for most
people. However, some people should check with their doctor before they start becoming much more physically active.
If you are planning to become much more physically active than you are now, start by answering the seven questions in the box below. If you are between the
ages of 15 and 69, the PAR-Q will tell you if you should check with your doctor before you start. If you are over 69 years of age, and you are not used to being
very active, check with your doctor.
Common sense is your best guide when you answer these questions. Please read the questions carefully and answer each one honestly: check YES or NO.
YES

NO

If
you
answered

1.

Has your doctor ever said that you have a heart condition and that you should only do physical activity
recommended by a doctor?

2.

Do you feel pain in your chest when you do physical activity?

3.

In the past month, have you had chest pain when you were not doing physical activity?

4.

Do you lose your balance because of dizziness or do you ever lose consciousness?

5.

Do you have a bone or joint problem (for example, back, knee or hip) that could be made worse by a
change in your physical activity?

6.

Is your doctor currently prescribing drugs (for example, water pills) for your blood pressure or heart con-
dition?

7.

Do you know of any other reason why you should not do physical activity?

YES to one or more questions
Talk with your doctor by phone or in person BEFORE you start becoming much more physically active or BEFORE you have a fitness appraisal. Tell
your doctor about the PAR-Q and which questions you answered YES.
• You may be able to do any activity you want — as long as you start slowly and build up gradually. Or, you may need to restrict your activities to
those which are safe for you. Talk with your doctor about the kinds of activities you wish to participate in and follow his/her advice.
• Find out which community programs are safe and helpful for you.

	 ➔

NO to all questions

If you answered NO honestly to all PAR-Q questions, you can be reasonably sure that you can:
• start becoming much more physically active – begin slowly and build up gradually. This is the
safest and easiest way to go.
• take part in a fitness appraisal – this is an excellent way to determine your basic fitness so
that you can plan the best way for you to live actively. It is also highly recommended that you
have your blood pressure evaluated. If your reading is over 144/94, talk with your doctor
before you start becoming much more physically active.

DELAY BECOMING MUCH MORE ACTIVE:
• if you are not feeling well because of a temporary illness such as
a cold or a fever – wait until you feel better; or
• if you are or may be pregnant – talk to your doctor before you
start becoming more active.

PLEASE NOTE: If your health changes so that you then answer YES to
any of the above questions, tell your fitness or health professional.
Ask whether you should change your physical activity plan.

Informed Use of the PAR-Q: The Canadian Society for Exercise Physiology, Health Canada, and their agents assume no liability for persons who undertake physical activity, and if in doubt after completing
this questionnaire, consult your doctor prior to physical activity.

No changes permitted. You are encouraged to photocopy the PAR-Q but only if you use the entire form.
NOTE: If the PAR-Q is being given to a person before he or she participates in a physical activity program or a fitness appraisal, this section may be used for legal or administrative purposes.

"I have read, understood and completed this questionnaire. Any questions I had were answered to my full satisfaction."
NAME ________________________________________________________________________
SIGNATURE _______________________________________________________________________________

DATE______________________________________________________

SIGNATURE OF PARENT _______________________________________________________________________
or GUARDIAN (for participants under the age of majority)

WITNESS ___________________________________________________

Note: This physical activity clearance is valid for a maximum of 12 months from the date it is completed and
becomes invalid if your condition changes so that you would answer YES to any of the seven questions.
© Canadian Society for Exercise Physiology

Supported by:

Health
Canada
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Santé
Canada

continued on other side...

APPENDIX D – PHYSICAL ACTIVITY ASSESSMENT FORMS
3.2 International Physical Activity Questionnaire (IPAQ)
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APPENDIX E – RECURRING SURVEYS
4.1 Baseline Measurement Worksheet
	
  
BASELINE	
  MEASUREMENTS	
  
	
  
	
  
ID________________________	
  	
  	
  	
  	
  	
  	
  	
  Date_____________________	
  
	
  
	
  
	
  
Age______________	
  	
  	
  	
  	
  Sex____________	
  	
  	
  	
  Height_______________	
  	
  Weight________________	
  
	
  
	
  
	
  
Date	
  of	
  last	
  menstrual	
  period	
  ____________________________	
  
	
  
	
  
	
  
Waist	
  __________________	
  	
  	
  	
  	
  Hip	
  	
  ___________________	
  	
  	
  	
  W/H	
  Ratio	
  __________________	
  	
  
	
  
	
  
Skinfold	
  measurements	
  
	
  
	
  
	
  
Male:	
  
	
  
	
  
	
  
Chest	
  ______________	
  	
  	
  	
  	
  	
  	
  	
  	
  _______________	
  	
  	
  	
  	
  	
  	
  	
  _________________	
  
	
  
	
  
	
  
	
  
	
  
Abdominal	
  	
  ______________	
  	
  	
  	
  	
  	
  	
  	
  	
  _______________	
  	
  	
  	
  	
  	
  	
  	
  _________________	
  	
  
	
  
	
  
	
  
	
  
	
  
Thigh	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  ______________	
  	
  	
  	
  	
  	
  	
  	
  	
  _______________	
  	
  	
  	
  	
  	
  	
  	
  _________________	
  
	
  
	
  	
  
	
  
	
  
	
  
Female:	
  
	
  
	
  
Triceps	
  	
  	
  	
  	
  	
  	
  	
  	
  ______________	
  	
  	
  	
  	
  	
  	
  	
  	
  _______________	
  	
  	
  	
  	
  	
  	
  	
  	
  _________________	
  
	
  
	
  
	
  
	
  
	
  
Suprailiac	
  	
  	
  	
  	
  ________________	
  	
  	
  	
  	
  	
  	
  	
  	
  _______________	
  	
  	
  	
  	
  	
  	
  	
  _________________	
  
	
  
	
  
	
  
	
  
	
  
Thigh	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  _________________	
  	
  	
  	
  	
  ________________	
  	
  	
  	
  	
  ________________	
  
	
  
	
  
	
  
Blood	
  collection	
  ____________	
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APPENDIX E – RECURRING SURVEYS
4.2 Weekly Self-Report Injury Questionnaire

ID _________

Date____________

Weekly Self-Report Injury Questionnaire
Use this log to record any injury which you may have experienced during the past week of
training. Record the severity score (1-4) and the impact score (A-D) by each symptom in the
column corresponding to the date.
INJURY
DATE
DATE
DATE
DATE DATE DATE DATE
Shin	
  Splints	
  
Patellofemoral syndrome
Pulled hamstring
IT Band syndrome
Ankle Sprain
Plantar Fasciitis
Achilles Tendonitis
Arch Pain
Knee Pain
Hip Pain
Groin Pain
Blisters
Other:
Did you visit the doctor?
Yes/No
Were there changes in your
daily routine? Yes/No
Was your training affected by
the injury? Yes/No
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DATE

APPENDIX E – RECURRING SURVEYS
4.3 Weekly Sickness Self-Assessment Questionnaire
Weekly Respiratory Symptom Self-Assessment Questionnaire
1.

Use your daily respiratory symptom self-assessment questionnaire to summarize the following
symptoms which you may or may have not have experienced within the last week. Record the
severity score (1-4) and the impact (A-D) by each symptom in the column corresponding to the
date.
*For example: insert a “2, B” in column “11/10” row “cough” if on the 10th of
November you experienced a mild cough that reduced the time or distance of
your activities.

Symptom
Cough
Sneezing
Sore Throat

DATE

DATE

DATE

DATE

DATE

DATE

DATE

Nasal Discharge
Stuffy Nose
Headache
Tiredness
Chilliness
Shaking Chills
Fever
Hoarseness
Aching muscle or joints
Watery or burning eyes.
Did you visit the doctor?
Yes/No
Were there changes in your daily
routine? Yes/No
Was your training effected by
illness? Yes/No

2.

Please report the number of hours spent training and the average intensity in each of the following
activities during the past week.
a. = low intensity, easy workouts
b. = moderate intensity, moderate workouts
c. = high intensity, intense workout

Mode of Activity
Swimming
Cycling
Running
Other Physical Activities

Weekly Training Time
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Average Intensity of Training

DATE

APPENDIX E – RECURRING SURVEYS
4.4 Athlete Burnout Questionnaire (ABQ)
Date: ________________

ID:_________

Please read each statement carefully and rate how often you experienced each item since
the last week. Substitute your specific sport (e.g., marathon training/running) when
reading the generic term [sport].

HOW OFTEN: Almost
Some Freque Almost
Statements:
never Rarely times ntly always
1. I’m accomplishing many worthwhile things in [sport].
1
2
3
4
5
2. I feel so tired from my training that I have trouble finding energy to
1
2
3
4
5
do other things.
3. The effort I spend in [sport] would be better spent doing other things.
1
2
3
4
5
1
2
3
4
5
4. I feel overly tired from my [sport] participation.
1
2
3
4
5
5. I am not achieving much in [sport].
6. I don’t care as much about my [sport] performance as I used to.
1
2
3
4
5
7. I am not performing up to my ability in [sport].
1
2
3
4
5
8. I feel “wiped out” from [sport].
1
2
3
4
5
1
2
3
4
5
9. I am not into [sport] like I used to be.
1
2
3
4
5
10. I feel physically worn out from [sport].
11. I feel less concerned about being successful in [sport] than I used to.
1
2
3
4
5
12. I am exhausted by the mental and physical demands of [sport].
1
2
3
4
5
2
3
4
5
13. It seems that no matter what I do, I don’t perform as well as I should. 1
14. I feel successful at [sport].
1
2
3
4
5
1
2
3
4
5
15. I have negative feelings toward [sport].

Subscales:
• Reduced sense of accomplishment: 1(REV), 5, 7, 13, 14(REV)
• Emotional/Physical exhaustion: 2, 4, 8, 10, 12,
• Devaluation: 3, 6, 9, 11, 15
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APPENDIX F – SENSORY EVALUATION FORMS
5.1 Preliminary Sport Nutrition Survey
ID________________________ Date___________________________
Sample___________________________

1. Will consuming food following exercise aid in recovery? Yes ( )

No ( )

Not sure ( )

2. How long after exercise do you eat or drink anything other than water?
0-30 minutes
( )

30-60 minutes
( )

60-90 minutes
( )

>90 minutes
( )

3. What do you consume at that time? ________________________________________________

4. Do you currently follow a post exercise recovery program including food? Yes ( )

No ( )

5. If so, briefly
describe___________________________________________________________________

6. Have you heard of or consumed kefir? Yes ( )

No ( )

7. If so, briefly define________________________________________________________

8. How often do you consume yogurt or other fermented dairy products (such as sour cream,
buttermilk, kefir, etc.)?
Never
( )
1

Once a week
( )
2

Two times a week
( )
3
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More than two times per week
( )
4

APPENDIX F – SENSORY EVALUATION FORMS
5.2 Product Evaluation Survey
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APPENDIX F – SENSORY EVALUATION FORMS
5.3 Exit Survey
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APPENDIX G – RAW DATA
6.1 JMP Output
Fit Group
Oneway Analysis of Sickness By GROUP
Oneway Anova
Summary of Fit
Rsquare

0.360867

Adj Rsquare

0.330432

Root Mean Square Error

2.918949

Mean of Response

3.179104

Observations (or Sum Wgts)
Analysis of Variance
Source

67

DF Sum of Squares Mean Square

GROUP
Error

3

303.07412

63

536.77662

F Ratio Prob > F

101.025 11.8570 <.0001*
8.520

C. Total 66
839.85075
Means for Oneway Anova
Level Number

Mean Std Error Lower 95% Upper 95%

ACC

21 2.14286

0.63697

0.870

3.4157

ACK

22 1.13636

0.62232

-0.107

2.3800

ETC

10 6.40000

0.92305

4.555

8.2446

ETK
14 5.64286 0.78012
4.084
Std Error uses a pooled estimate of error variance
Means Comparisons
Comparisons for all pairs using Tukey-Kramer HSD
Confidence Quantile

7.2018

q* Alpha
2.63895 0.05
LSD Threshold Matrix
Abs(Dif)-HSD
ETC

ETK

ACC

ACK

ETC -3.4449 -2.4322

1.2976

2.3258

ETK -2.4322 -2.9114

0.8422

1.8730

ACC

1.2976

0.8422 -2.3772 -1.3435

ACK 2.3258 1.8730 -1.3435 -2.3225
Positive values show pairs of means that are significantly different.
Connecting Letters Report
Level

Mean

ETC

A

ETK

A

6.4000000
5.6428571

ACC

B

2.1428571

ACK

B

1.1363636
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Levels not connected by same letter are significantly different.
Ordered Differences Report
Level - Level Difference Std Err Dif Lower CL Upper CL p-Value
ETC

ACK

5.263636

1.113244

2.32584

8.201433 <.0001*

ETK

ACK

4.506494

0.997935

1.87299

7.139998 0.0002*

ETC

ACC

4.257143

1.121496

1.29757

7.216718 0.0018*

ETK

ACC

3.500000

1.007133

0.84222

6.157777 0.0050*

ACC

ACK

1.006494

0.890512

-1.34353

3.356512

0.6724

ETC

ETK

0.757143

1.208560

-2.43219

3.946475

0.9232

Oneway Analysis of Injury By GROUP
Oneway Anova
Summary of Fit
Rsquare

0.528986

Adj Rsquare

0.506557

Root Mean Square Error

2.720064

Mean of Response

3.283582

Observations (or Sum Wgts)
Analysis of Variance
Source

DF Sum of Squares Mean Square

GROUP
Error

67

3

523.49073

63

466.12121

F Ratio Prob > F

174.497 23.5846 <.0001*
7.399

C. Total 66
989.61194
Means for Oneway Anova
Level Number

Mean Std Error Lower 95% Upper 95%

ACC

21 0.95238

0.59357

-0.234

2.1385

ACK

22 1.45455

0.57992

0.296

2.6134

ETC

10 6.50000

0.86016

4.781

8.2189

ETK
14 7.35714 0.72697
5.904
Std Error uses a pooled estimate of error variance
Means Comparisons
Comparisons for all pairs using Tukey-Kramer HSD
Confidence Quantile

8.8099

q* Alpha
2.63895 0.05
LSD Threshold Matrix
Abs(Dif)-HSD
ETK

ETC

ACK

ACC

ETK -2.7131 -2.1149

3.4485

3.9281

ETC -2.1149 -3.2102

2.3078

2.7897

ACK

3.4485

2.3078 -2.1643 -1.6877

ACC 3.9281 2.7897 -1.6877 -2.2152
Positive values show pairs of means that are significantly different.
Connecting Letters Report
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Level

Mean

ETK

A

7.3571429

ETC

A

6.5000000

ACK

B

1.4545455

ACC
B
0.9523810
Levels not connected by same letter are significantly different.
Ordered Differences Report
Level - Level Difference Std Err Dif Lower CL Upper CL p-Value
ETK

ACC

6.404762

0.938511

3.92808

8.881449 <.0001*

ETK

ACK

5.902597

0.929940

3.44853

8.356666 <.0001*

ETC

ACC

5.547619

1.045082

2.78970

8.305541 <.0001*

ETC

ACK

5.045455

1.037392

2.30783

7.783082 <.0001*

ETK

ETC

0.857143

1.126214

-2.11488

3.829167

0.8716

ACK ACC

0.502165

0.829836

-1.68773

2.692063

0.9301

Oneway Analysis of Emotional Physical Exhaustion By GROUP
Oneway Anova
Summary of Fit
Rsquare

0.026843

Adj Rsquare

-0.0195

Root Mean Square Error

0.637305

Mean of Response

1.895513

Observations (or Sum Wgts)
Analysis of Variance
Source
GROUP
Error

67

DF Sum of Squares Mean Square F Ratio Prob > F
3

0.705810

63

25.587945

0.235270 0.5793

0.6308

0.406158

C. Total 66
26.293756
Means for Oneway Anova
Level Number

Mean Std Error Lower 95% Upper 95%

ACC

21 1.80062

0.13907

1.5227

2.0785

ACK

22 1.90433

0.13587

1.6328

2.1759

ETC

10 1.82154

0.20153

1.4188

2.2243

ETK
14 2.07683 0.17033
1.7365
Std Error uses a pooled estimate of error variance
Means Comparisons
Comparisons for all pairs using Tukey-Kramer HSD
Confidence Quantile
q* Alpha
2.63895 0.05
LSD Threshold Matrix
Abs(Dif)-HSD
ETK

ACK

ETC

ACC

ETK -0.63567 -0.40248 -0.44104 -0.30407
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2.4172

ACK -0.40248 -0.50709 -0.55863 -0.40938
ETC -0.44104 -0.55863 -0.75213 -0.62526
ACC -0.30407 -0.40938 -0.62526 -0.51902
Positive values show pairs of means that are significantly different.
Connecting Letters Report
Level
ETK

Mean
A

2.0768348

ACK A

1.9043282

ETC

1.8215385

A

ACC A
1.8006216
Levels not connected by same letter are significantly different.
Ordered Differences Report
Level - Level Difference Std Err Dif Lower CL

Upper CL p-Value

ETK

ACC

0.2762132 0.2198912 -0.304069 0.8564956

0.5939

ETK

ETC

0.2552964 0.2638694 -0.441042 0.9516352

0.7683

ETK

ACK

0.1725066 0.2178830 -0.402476 0.7474895

0.8579

ACK ACC

0.1037066 0.1944288 -0.409382 0.6167951

0.9506

ACK ETC

0.0827898 0.2430587 -0.558630 0.7242100

0.9863

ETC

0.0209169 0.2448604 -0.625258 0.6670920

0.9998

ACC

Oneway Analysis of Sense of Accomplishment By GROUP
Oneway Anova
Summary of Fit
Rsquare

0.049931

Adj Rsquare

0.004689

Root Mean Square Error

0.555059

Mean of Response

2.046499

Observations (or Sum Wgts)
Analysis of Variance
Source
GROUP
Error

67

DF Sum of Squares Mean Square F Ratio Prob > F
3

1.020070

63

19.409690

0.340023 1.1036

0.3543

0.308090

C. Total 66
20.429761
Means for Oneway Anova
Level Number

Mean Std Error Lower 95% Upper 95%

ACC

21 1.91513

0.12112

1.6731

2.1572

ACK

22 2.16795

0.11834

1.9315

2.4044

ETC

10 1.91078

0.17553

1.5600

2.2615

ETK
14 2.14964 0.14835
1.8532
Std Error uses a pooled estimate of error variance
Means Comparisons
Comparisons for all pairs using Tukey-Kramer HSD
Confidence Quantile
q* Alpha
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2.4461

2.63895 0.05
LSD Threshold Matrix
Abs(Dif)-HSD
ACK

ETK

ACC

ETC

ACK -0.44165 -0.48246 -0.19405 -0.30147
ETK -0.48246 -0.55363 -0.27089 -0.36762
ACC -0.19405 -0.27089 -0.45204 -0.55844
ETC -0.30147 -0.36762 -0.55844 -0.65507
Positive values show pairs of means that are significantly different.
Connecting Letters Report
Level

Mean

ACK A

2.1679540

ETK

A

2.1496387

ACC

A

1.9151293

ETC A
1.9107809
Levels not connected by same letter are significantly different.
Ordered Differences Report
Level - Level Difference Std Err Dif Lower CL

Upper CL p-Value

ACK ETC

0.2571731 0.2116911 -0.301470 0.8158160

0.6198

ACK ACC

0.2528247 0.1693372 -0.194048 0.6996974

0.4477

ETK

ETC

0.2388578 0.2298162 -0.367616 0.8453319

0.7271

ETK

ACC

0.2345094 0.1915135 -0.270886 0.7399044

0.6138

ACK ETK

0.0183153 0.1897645 -0.482464 0.5190948

0.9997

ACC

0.0043484 0.2132604 -0.558436 0.5671325

1.0000

ETC

Oneway Analysis of Sport Devaluation By GROUP
Oneway Anova
Summary of Fit
Rsquare

0.085363

Adj Rsquare

0.041809

Root Mean Square Error

0.637774

Mean of Response

1.772923

Observations (or Sum Wgts)
Analysis of Variance
Source
GROUP
Error

67

DF Sum of Squares Mean Square F Ratio Prob > F
3

2.391639

63

25.625606

0.797213 1.9599

0.1291

0.406756

C. Total 66
28.017245
Means for Oneway Anova
Level Number

Mean Std Error Lower 95% Upper 95%

ACC

21 1.64727

0.13917

1.3692

1.9254

ACK

22 2.04300

0.13597

1.7713

2.3147

ETC

10 1.64195

0.20168

1.2389

2.0450
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ETK
14 1.63055 0.17045
1.2899
Std Error uses a pooled estimate of error variance
Means Comparisons
Comparisons for all pairs using Tukey-Kramer HSD
Confidence Quantile

1.9712

q* Alpha
2.63895 0.05
LSD Threshold Matrix
Abs(Dif)-HSD
ACK

ACC

ETC

ETK

ACK -0.50746 -0.11773 -0.24084 -0.16295
ACC -0.11773 -0.51940 -0.64133 -0.56399
ETC -0.24084 -0.64133 -0.75269 -0.68545
ETK -0.16295 -0.56399 -0.68545 -0.63614
Positive values show pairs of means that are significantly different.
Connecting Letters Report
Level

Mean

ACK A

2.0430017

ACC

A

1.6472694

ETC

A

1.6419464

ETK A
1.6305478
Levels not connected by same letter are significantly different.
Ordered Differences Report
Level - Level Difference Std Err Dif Lower CL Upper CL p-Value
ACK ETK

0.4124539 0.2180433 -0.162952

0.987860

0.2420

ACK ETC

0.4010553 0.2432375 -0.240837

1.042947

0.3593

ACK ACC

0.3957323 0.1945719 -0.117734

0.909198

0.1867

ACC

ETK

0.0167216 0.2200529 -0.563988

0.597431

0.9998

ETC

ETK

0.0113986 0.2640635 -0.685452

0.708250

1.0000

ACC

ETC

0.0053230 0.2450406 -0.641327

0.651973

1.0000
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